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Intraparenchymal Hemorrhage
Abstract
Stroke caused by intraparenchymal hemorrhage (IPH) is most commonly the result of hypertensioninduced blood vessel rupture in the brain and is associated with devastating disability and high rates of
death. To date, no intervention has improved outcomes in IPH stroke patients; however, head elevation
may be one of the most important first steps to promote clinical stability in the hyperacute stage of IPH
stroke because of the risk of increased intracranial pressure (ICP) in these patients. Nursing research
completed in the late 1970s and early 1980s in patients with increased ICP due to traumatic brain injury
showed that elevating the head of bed (HOB) increased gravity drainage of venous blood and
cerebrospinal fluid, lowering ICP, However, no study has yet been completed in a generalizable sample of
hyperacute IPH stroke patients to examine serial changes in clinical stability in relation to HOB
positioning.
Recently, the Head Position in Stroke Trial (HeadPoST), which enrolled a highly heterogeneous sample of
subacute stroke patients, found that head position does not affect 3-month outcome; however, the study
was heavily criticized by international stroke experts due to significant internal validity concerns.
HeadPoST findings have created significant confusion within the acute stroke practice community about
whether there is a role for head positioning in hyperacute IPH stroke management.
The focus of our research was to build knowledge of key clinical methods that will support future
definitive HOB research in hyperacute IPH stroke patients. We established 1) the clinical knowledge and
skill set supporting nurses’ ability to localize stroke disability within vascular territories in the brain and 2)
use of the National Institutes of Health Stroke Scale as a valid assessment tool for serial monitoring of
clinical change in hyperacute IPH patients. We also 3) examined the degree of acceptance of HeadPoST
findings internationally among nurse and physician clinicians caring for IPH stroke patients and 4)
evaluated elements tied to the feasibility of conducting hyperacute IPH HOB research at a large,
comprehensive stroke center in the Midsouth. Collectively, the chapters in this dissertation create a
foundation for future IPH head-positioning research, providing direction for our next steps in
understanding the contribution of HOB positioning to hyperacute IPH patient management.
Patients with hypertensive IPH stroke suffer significantly higher rates of disability and death compared to
other forms of stroke, yet despite a great deal of inquiry into interventions to improve outcomes, none
have been successful. Positioning the patient’s HOB at 30-degrees may be one of the most important
early interventions that nurses can employ to impart stability in hypertensive IPH patients. Our research
and conclusions position nurse scientists to further their examination of the effect of this simple HOBpositioning intervention in this highly vulnerable patient population.
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ABSTRACT

Stroke caused by intraparenchymal hemorrhage (IPH) is most commonly the
result of hypertension-induced blood vessel rupture in the brain and is associated with
devastating disability and high rates of death. To date, no intervention has improved
outcomes in IPH stroke patients; however, head elevation may be one of the most
important first steps to promote clinical stability in the hyperacute stage of IPH stroke
because of the risk of increased intracranial pressure (ICP) in these patients. Nursing
research completed in the late 1970s and early 1980s in patients with increased ICP due
to traumatic brain injury showed that elevating the head of bed (HOB) increased gravity
drainage of venous blood and cerebrospinal fluid, lowering ICP. However, no study has
yet been completed in a generalizable sample of hyperacute IPH stroke patients to
examine serial changes in clinical stability in relation to HOB positioning.
Recently, the Head Position in Stroke Trial (HeadPoST), which enrolled a highly
heterogeneous sample of subacute stroke patients, found that head position does not
affect 3-month outcome; however, the study was heavily criticized by international stroke
experts due to significant internal validity concerns. HeadPoST findings have created
significant confusion within the acute stroke practice community about whether there is a
role for head positioning in hyperacute IPH stroke management.
The focus of our research was to build knowledge of key clinical methods that
will support future definitive HOB research in hyperacute IPH stroke patients. We
established 1) the clinical knowledge and skill set supporting nurses’ ability to localize
stroke disability within vascular territories in the brain and 2) use of the National
Institutes of Health Stroke Scale as a valid assessment tool for serial monitoring of
clinical change in hyperacute IPH patients. We also 3) examined the degree of acceptance
of HeadPoST findings internationally among nurse and physician clinicians caring for
IPH stroke patients and 4) evaluated elements tied to the feasibility of conducting
hyperacute IPH HOB research at a large, comprehensive stroke center in the Mid-South.
Collectively, the chapters in this dissertation create a foundation for future IPH headpositioning research, providing direction for our next steps in understanding the
contribution of HOB positioning to hyperacute IPH patient management.
Patients with hypertensive IPH stroke suffer significantly higher rates of disability
and death compared to other forms of stroke, yet despite a great deal of inquiry into
interventions to improve outcomes, none have been successful. Positioning the patient’s
HOB at 30-degrees may be one of the most important early interventions that nurses can
employ to impart stability in hypertensive IPH patients. Our research and conclusions
position nurse scientists to further their examination of the effect of this simple HOBpositioning intervention in this highly vulnerable patient population.
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CHAPTER 1.

INTRODUCTION

Overview
Stroke is the fifth leading cause of death in the United States with an estimated
795,000 people experiencing a new or recurrent stroke each year (Hemphill et al., 2015).
Ischemic stroke, resulting from insufficient arterial blood flow to the brain, is the most
prevalent (80%) type of stroke. Hemorrhagic stroke with less prevalence (20%), is
caused from a rupture in an arterial blood vessel causing blood to leak into the
surrounding brain tissue. The terms intracerebral hemorrhage (ICH) and intraparenchymal brain hemorrhage (IPH) are both used to describe a spontaneous, nontraumatic hemorrhage within brain tissue and are used interchangeably, with the term
IPH more physiologically correct and the term ICH favored by some as traditional
terminology. The focus of the research presented in this work is hypertensive IPH. While
a variety of pathogenic mechanisms may cause IPH, uncontrolled hypertension is by far
the most common (An et al., 2017; Hemphill et al., 2015; Qureshi, Mendelow, et al.,
2009; Qureshi, Tuhrim, et al., 2009).
Although the prevalence of hemorrhagic stroke is significantly lower than
ischemic stroke, IPH is the most devastating form of stroke, resulting in severe disability
and high rates of death (Kim & Bae, 2017). Overall, IPH has a fatality rate of
approximately 40% at one month and 54% at one year (An et al., 2017) with nearly half
of all patients dying within the first 24 hours (Elliott & Smith, 2010). Of those IPH
patients that do survive, only 12-30% achieve long-term functional independence (An et
al., 2017). Additionally, up to 40% of these patients experience hematoma expansion
(Dowlatshahi et al., 2011; Ovesen et al., 2014; Yu et al., 2017), usually occurring within
the first 24 hours, which is an independent predictor of early neurological deterioration
(Brott et al., 1997; Leira et al., 2004), poor functional outcome, and death (Davis et al.,
2006; Delcourt et al., 2012).
The most important risk factor for IPH is hypertension, with smoking, excessive
alcohol consumption, hypocholesterolemia, and illicit drug use recognized as risk factors
that can further potentiate poorly controlled hypertension to cause vessel rupture and/
coagulopathies (An et al., 2017). Significant hypertension tears the small penetrating
arteries that emerge from the trunk of large arteries that make up the circle of Willis,
causing hemorrhages that occur in predictable locations, including the basal ganglia,
thalamus, pons, or cerebellum (Qureshi, et al., 2009). As the most powerful determinant
of risk for IPH, use of antihypertensive medication resulting in control of hypertension
significantly decreases risk and incidence (Benjamin et al., 2019).
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Conceptual Framework

Pathophysiologic Antecedents of Intraparenchymal Hemorrhage
Pathophysiologic antecedents (risk factors) associated with brain hemorrhages are
classified as non-modifiable and modifiable. Non-modifiable risk factors include
structural anomalies such as amyloid angiopathy with associated microbleeds, vascular
malformations, intracranial aneurysms, and brain tumors―in particular metastatic
tumors; additional non-modifiable factors include Asian or African American race, male
sex, and age (Al-Mufti et al., 2018; Hemphill et al., 2015). For hypertensive IPH
specifically, non-modifiable risk factors primarily encompass age, male sex, and Asian or
African American race. Modifiable risk factors associated with IPH include hypertension,
coagulopathy secondary to oral anticoagulant use, antiplatelet use, alcohol use, and
smoking (Al-Mufti et al., 2018; Hemphill et al., 2015).

Mechanism of Injury in ICH

Primary Injury
Hypertensive IPH is the result of chronic hypertension-induced lipohyalinosis
(small vessel disease) that weakens arterial walls (An et al., 2017). These small arteries
emerge from the trunks of the large vessels of the circle of Willis, penetrating deep into
brain territories. High perfusion pressures tear these diseased vessels causing
hypertensive IPH to occur in predictable locations (as described above) (Qureshi,
Tuhrim, et al., 2009) that disrupts the brain tissue and its normal function (Al-Mufti et al.,
2018). The damage caused by IPH can occur within minutes to hours, depending on the
rate of hematoma growth which occurs in a cascaded fashion (Al-Mufti et al., 2018).
Hemostasis is initiated by local activation of hemostatic pathways and mechanical
tamponade; however, as many as 73% of patients may have some degree of hematoma
enlargement (Davis et al., 2006). Primary brain damage is the result of mechanical
distortion associated with the hematoma’s mass effect (Qureshi, et al., 2009) and is
generally thought to have the greatest influence on patient outcomes (Al-Mufti et al.,
2018).

Secondary Injury
Secondary damage is caused by the toxic effects of blood on brain tissue
(Aronowski & Zhao, 2011) and may be dependent on the initial hematoma volume,
hematoma age, and/or intraventricular volume, including hydrocephalus which may
ensue from disruption of ventricular cerebrospinal fluid (CSF) drainage (Qureshi, et al.,
2009). Many parallel pathological pathways are thought to contribute to secondary injury,
including the cytotoxicity of blood (Xi et al., 2006), hypermetabolic effects,
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excitotoxicity (Qureshi et al., 2003), and inflammation (Aronowski & Xiurong, 2011).
Over the course of days, these processes lead to irreversible destruction of both gray
matter cell bodies and white matter tracts and are followed by blood-brain barrier
disruption and brain edema from widespread cellular death (Aronowski & Xiurong,
2011). Inflammatory mediators responding to cellular death or injury also have the
capacity to further secondary injury (Aronowski & Xiurong, 2011). Following the IPH
event, a strong cytotoxic, pro-oxidative and pro-inflammatory insult also occurs within
adjacent healthy brain tissue. Part of this process is the lysis of red blood cells that
begins approximately 24 hours post ictus and continues for several days, releasing
cytotoxic hemoglobin that further damages the surrounding cells, with hemoglobin and
its degradation products (heme and iron) directly compromising the well-being of
neighboring brain cells (Aronowski & Xiurong, 2011). The pathogenesis of IPH is a
fascinating yet not well-understood process, worthy of continued basic scientific
exploration.

Clinical Findings Predictive of IPH Outcomes
Clinical and radiographic findings found to be predictive of poor IPH outcome
include the admission Glasgow Coma Scale, malignant hypertension, fever, and
hematoma volume >30 cc as well as hematoma location, hematoma expansion, presence
of a “spot” or “swirl” sign, perihematomal edema, intraventricular hemorrhage,
hydrocephalus, midline brain shift and seizures (Hemphill et al., 2015). In particular,
large hematoma volume, intraventricular blood, and midline shift have shown to predict
high mortality (Al-Mufti et al., 2018; Davis et al., 2006; Hemphill et al., 2001; Rost et al.,
2008). Other factors known to contribute to poor outcome include advanced age (>80
years), premorbid functional state (including premorbid cognitive impairment),
hyperglycemia, coagulopathy, neutrophil/lymphocyte ratio (>4.58), serum fibrinogen
level (>523 mg/dl), and early change of resuscitation status (Al-Mufti et al., 2018).

The Role of Intracranial Pressure
Intracranial pressure (ICP) is described as the pressure inside of the cranium. The
Monro-Kellie doctrine (Figure 1-1) describes the pressure-volume relationship between
intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in relation to the
volume of cerebrospinal fluid (CSF), blood, and brain tissue that are present within the
cranium (Kellie & Royal College of Surgeons of England, 1824; Mokri, 2001). The
doctrine states that the skull, which protects the brain, forms a non-expandable cranial
vault (also called the cranial compartment), an area that is non-elastic and has a fixed
volume that normally lies in a state of equilibrium. There are three space-occupying
components within the cranial vault. Brain tissue accounts for approximately 80% of the
contents and CSF accounts for approximately 10% of the contents. The remainder is
occupied by arterial and venous blood (Greenberg, 2016; Leffert & Schwamm, 2013;
Morton & Ellenbogen, 2012).
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Figure 1-1. Monroe-Kellie Hypothesis
CSF, cerebral spinal fluid; ICP, intraparenchymal hemorrhagic [stroke]; CPP, cerebral
perfusion pressure.
Data Source: Mokri, B. (2001). The Monro-Kellie hypothesis: Applications in CSF volume depletion. Neurology, 56(12), 1746–1748. https://doi.org/10.1212/wnl.56.12.1746
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The volume within the cranial vault is constant under normal conditions and
maintains a normal steady ICP between 0-15 mmHg. This pressure remains constant as
long as the volumes of the three intracranial contents remain constant (Greenberg, 2016;
Leffert & Schwamm, 2013; Morton & Ellenbogen, 2012). If there is an increase in the
volume of either the brain tissue, blood, or CSF, there must be a corresponding decrease
in the volume of the other contents (Greenberg, 2016; Mokri, 2001).
In the case of IPH, the blood volume component increases within the cranium,
thereby placing the patient at risk of increased ICP. Elevated ICP may cause further
injury to the patient due to brain ischemia from a reduction in CPP and/or brain
herniation.

Significance and Purpose
The care of IPH stroke patients is largely prescribed by the current guidelines
published by the American Heart Association, with the last publication in 2015. Since
that time, there have been new and continued studies that likely support changes in these
guidelines. While there have been several advances in IPH clinical knowledge in recent
years, no interventions have translated into mainstream clinical practice to improve
patient outcomes (Hanley et al., 2017; Hanley et al., 2019; Mendelow et al., 2013;
Qureshi et al., 2014; Qureshi et al., 2016). Because of this, it is important to continue
exploring and evaluating interventions that could impact outcomes in this patient
population.
The optimal head of bed (HOB) position in various types of stroke may be
important to ensure clinical stability, especially in the hyperacute stage of the
management. In keeping with the Monro-Kellie doctrine, IPH stroke patients may be at
significant risk for increased ICP; therefore, elevation of the HOB may facilitate
gravitational venous blood and cerebral spinal fluid drainage from within the skull.
Interestingly, there is little to no mention in the United States, European, Australian, and
Canadian guidelines of HOB positioning’s role or value in acute stroke management.
Most of the previous work examining HOB height has been conducted in hyperacute
ischemic stroke (Ali et al., 2017; Anderson et al., 2017; Aries et al., 2013; Favilla et al.,
2014; Hayashida et al., 1993; Hunter et al., 2011; Olavarría et al., 2014; Ouchi et al.,
2001; Palazzo et al., 2016; Saqqur et al., 2010; Schwarz Stefan et al., 2002; Wojner et al.,
2002; Wojner-Alexandrov et al., 2005), whereas few papers have examined optimal HOB
height in patients with brain hemorrhage, these heterogeneous patient samples blur our
understanding of whether positioning is important in IPH (Feldman et al., 1992; Mahfoud
et al., 2010; Rosner & Coley, 1986). The Head Position in Stroke Trial (HeadPoST)
attempted to definitively answer the optimal HOB position question in all types of stroke
(Anderson et al., 2017), including IPH, but numerous methodologic flaws challenge the
study’s internal validity (Alexandrov et al., 2018).
This dissertation methodically explores nursing clinical assessment knowledge,
the usefulness of existing clinical disability measures, practitioners’ perceptions tied to
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HOB positioning for IPH patients, and the feasibility of conducting HOB position
research in hyperacute IPH patients in support of the design and definitive testing of an
HOB position intervention for IPH patients. Collectively, the four scientific chapters
presented here produce findings indicating a need for further research to uncover the
value of this relatively simple nursing intervention to promote stability or improvement in
hyperacute patient outcomes. General information for each section is described below.

Clinical Localization of Acute Stroke Symptoms
Chapter 2 examines and builds knowledge on clinical localization as an essential
part of nursing’s clinical assessment skills. Clinical localization is the process of aligning
stroke symptoms with specific vascular territories in the brain (Alexandrov, 2012; Brazis
et al., 2016; Brodmann, 1909; Chandra et al., 2017; Iqbal, 2013). Localization is the
bedrock of clinical assessment in acute stroke patients and assists interdisciplinary
clinicians in understanding clinical worsening or improvement, yet few nurses have
knowledge of localization principles. The conduct of HOB positioning research must be
supported by the fundamental knowledge of clinical localization to ensure patient safety
with the ongoing assessment of worsening or improvement in relation to HOB height and
IPH characteristics.

Validity of the National Institutes of Health Stroke Scale in Hyperacute IPH
Patients
Few studies have explored head positioning in hyperacute IPH patients using a
serial monitoring approach to understand benefit or harm associated with the intervention
(Feldman et al., 1992; Mahfoud et al., 2010; Rosner & Coley, 1986). Interestingly, these
HOB studies utilized ICP as the dependent variable, with the patients enrolled
constituting a variety of clinical diagnoses; only a small number were IPH cases.
Increased ICP may be a real concern in patients with IPH, although reports of increased
ICP vary significantly in this patient population (Chambers et al., 2001; Diringer et al.,
1998; Huttner et al., 2006; Huttner et al., 2007). Additionally, not all patients with IPH
undergo ICP monitoring (Chen et al., 2019; Hemphill et al., 2015), making use of a valid
and reliable clinical disability measure essential to support serial assessments of clinical
worsening or improvement. Chapter 3 examines the validity of the National Institutes of
Health Stroke Scale (NIHSS) as a measure of clinical disability in IPH patients.

Head Positioning Beliefs and Practices of Neurocritical Care Providers
As discussed briefly, the HeadPoST study attempted to determine whether HOB
could serve as a treatment for acute stroke capable of improving 3-month functional
outcome in both ischemic and IPH patients; the study found no difference in 3-month
functional status and concluded that HOB height makes no difference in the management
of IPH patients (Anderson et al., 2017). However, multiple methodologic issues
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challenge the internal validity of HeadPoST, and chief among these was failure to
perform serial monitoring of clinical worsening or improvement during the intervention
(Alexandrov et al., 2018). Since the publication of HeadPoST, international guidelines
make no recommendations on the use of head positioning for IPH patients (Stroke
Foundation, (n.d); Shoamanesh et al., 2021; Steiner et al., 2014), and it remains unclear
whether practitioners worldwide have been influenced by the study’s findings. Chapter 4
examines practitioners’ beliefs, clinical practices, and recommendations for future HOB
positioning research in IPH patients.

Exploratory Study of Intraparenchymal Hemorrhage
The feasibility of HOB positioning research in hyperacute IPH patients is largely
dependent on the availability of subjects. This population has a less common form of
stroke as well as a number of other clinical factors such as use of technology-derived
measures (i.e. ICP monitoring, brain tissue oxygenation monitoring) and neuroimaging
findings. Additionally, traditions supporting how IPH patients are positioned may also
interfere with the conduct of HOB research. Chapter 5 examines issues tied to future
research feasibility in an effort to understand how best to design and recruit a sufficient
sample of hyperacute IPH patients to test a HOB intervention.

Summary
Patients with IPH suffer significantly high rates of disability and death. Sadly, to
date interventions capable of improving IPH outcomes are lacking. As the largest group
of the healthcare team, nurses offer a holistic approach to care and are present at the
bedside triaging, assessing and monitoring patients. Nurses caring for hyperacute IPH
patients must possess the clinical knowledge and skills to better assess and manage this
patient population. The work of this dissertation seeks to improve both nursing and
medical knowledge, while setting the stage for design and implementation of more
definitive contributions to science in the realm of HOB positioning for IPH patients.
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CHAPTER 2.

CLINICAL LOCALIZATION OF STROKE1

Introduction
Clinical localization is the process of aligning stroke symptoms with specific
vascular territories in the brain (Alexandrov, 2012; Brazis et al., 2016; Brodmann, 1909;
Chandra et al., 2017; Iqbal, 2013). While non-contrast computed tomography (CT) is
essential to rule out hemorrhage, patients early into ischemic stroke (< 6 hours) often
present with normal CT scans; therefore, ischemic stroke is a clinical diagnosis
dependent on localization of symptoms to specific arterial distributions. Localization is
rarely taught to non-neurologists; it is a skill that requires knowledge of brain anatomy
and physiology in relation to the arterial vasculature (Brazis et al., 2016; Iqbal, 2013).
But nurses intent on developing expertise in acute stroke management are well served to
understand at least the most classic stroke findings associated with arterial clinical
localization to support their understanding of stroke progression or improvement and to
assist in prognostication of patient outcomes.

Clinical Localization of Acute Stroke
The brain is made up of discreet sections that each have unique functions; when
injured, these areas produce disabilities that examiners identify in symptom clusters
representative of discreet arterial brain regions. Localization is dependent on an
understanding of the physiology within each area of the brain alongside the vasculature
associated with these regions so that stroke arterial distribution is identified (Alexandrov,
2012; Brazis et al., 2016).
Brodmann’s Classification and Cortical Arterial Distribution
In the early 1900s, Brodmann mapped what is called the “cytoarchitecture of the
brain” (Figure 2-1), a numbered system classifying cerebral cortical physiology in
relation to autopsy findings demonstrating infarction or injury (Brodmann, 1909). While
the system is incomplete, Brodmann’s classification remains the classic model informing
practitioners today about discreet areas within the brain that are responsible for important
cortical functions. Stroke clinical localization combines knowledge of Brodmann’s
classification with an understanding of the vasculature that serves these regions so that
symptoms suggesting abnormal function may be associated with reduced blood flow in a
discreet portion of an artery (Brazis et al., 2016).

1 Reprinted with permission from final submission. Dusenbury, W., & Alexandrov, A. W. (2020). Clinical Localization

of Stroke. Critical Care Nursing Clinics of North America, 32(1), 1-19. https://doi.org/10.1016/j.cnc.2019.10.001

8

Figure 2-1. Brodmann’s Cytoarchitecture of the Brain
Reprinted with permission. Alexandrov, A.W. (2012). Correlated anatomy,
pathophysiology and clinical examination, Association of Neurovascular Clinicians core
curriculum for neurovascular nursing. Health Outcomes Institute, Inc., Fountain Hills,
Arizona p. 43.
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The brain’s arterial distribution is divided into anterior and posterior divisions
(Figure 2-2). Most blood flow is directed to the anterior circulation of the brain, which is
derived from the internal carotid arteries (ICA). In approximately 70% of individuals, the
ICA arise from the common carotid arteries (CCA) bilaterally, with the right CCA arising
from the innominate artery and the left CCA arising directly from the aortic arch.
However, the most common arch variant occurring in about 13% of individuals is the
“bovine aortic arch” where the left common carotid either shares its origin with the right
CCA in the innominate artery, or it arises from the innominate artery more distally than
the right CCA. Bovine aortic arch presentations are more common among Blacks than
Whites, although the reason is unknown. Regardless of its origin, the CCA bifurcates into
the external carotid artery, which goes on to supply the face and other head structures,
and the ICA, which travels deep within the brain, ultimately giving off the ophthalmic
arteries (OA), the two posterior communicating arteries (PcomA), the anterior cerebral
arteries (ACA), and the middle cerebral arteries (MCA). The posterior circulation of the
brain is derived from the vertebral arteries (VA). The right VA arises from the
innominate artery, which then goes on to become the right subclavian artery, while the
left subclavian arises from the aortic arch and gives off the left VA. The VA travel
through along the vertebral column, winding their way up the neck into the skull where
they give off the posterior inferior cerebellar arteries (PICA) and the anterior spinal
arteries. At the level of the pons, the VA fuse to form the single basilar artery (BA),
which ultimately gives off the anterior inferior cerebellar arteries (AICA), the superior
cerebellar arteries (SCA), and at the most distal aspect of the BA, the posterior cerebral
arteries (PCA). Both the anterior and posterior circuits connect deep within the brain to
form the circle of Willis (Alexandrov, 2012; Chandra et al., 2017).
The three main pairs of arteries supplying the cerebral cortex are the MCAs
(largest distribution covering the lateral and inferior aspects of the frontal, parietal and
temporal lobes), the ACAs (covering the anterior and superior-medial aspects of the
frontal lobes, and the superior-medial aspects of the parietal lobes), and the PCAs
(covering the occipital lobe, lateral-posterior-inferior aspects of the parietal lobes, as well
as the thalamus, and the superior aspects of the brainstem and cerebellum) (Chandra et
al., 2017). Figure 2-3 illustrates cortical arterial distribution for the MCA, ACA, and
PCA bilaterally; knowledge of this arterial layout is essential to support an understanding
of cortical stroke clinical localization (Brazis et al., 2016). The first portions of the MCA,
ACA, and PCA arteries prior to any bifurcation are commonly called the M1, A1, or P1
segments, respectively, while the segments after bifurcations are commonly referred to as
M2, A2, or P2 segments; numbering each of these divisions continues as the arterial
distribution progresses further from their point of origin. The single anterior
communicating artery (AcomA) is situated at the A1-A2 bifurcation connecting the right
and left ACAs, while the two PcomAs, which originate from the ICAs bilaterally, move
posterior, ultimately connecting at the P1-P2 bifurcation of the PCAs (Chandra et al.,
2017). While estimates vary depending on reports, as many as 50% of patient samples
have been found to lack “complete” circles of Willis; most commonly these anomalies
involve one of the following (Iqbal, 2013):
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Figure 2-2. Arterial Vasculature of the Brain
ACA, anterior cerebral artery; AcomA, anterior communicating artery; MCA, middle
cerebral artery; ICA, internal carotid artery; PcomA, posterior communicating artery;
PCA, posterior cerebral artery; SCA, superior inferior cerebellar artery; BA, basilar
artery; AICA, anterior inferior cerebellar artery; VA, vertebral artery; PICA, posterior
inferior cerebellar artery.
Reprinted with permission. Alexandrov, A.W. (2012). Correlated anatomy,
pathophysiology and clinical examination, Association of Neurovascular Clinicians core
curriculum for neurovascular nursing. Health Outcomes Institute, Inc., Fountain Hills,
Arizona, p. 41.
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Figure 2-3. Cortical Arterial Distribution
Left: View from the inferior base of the cortex. Right: Superior axial view of the cortex.
Dark gray: middle cerebral artery distribution; light gray: anterior cerebral artery
distribution; speckled gray: posterior cerebral artery distribution.
Reprinted with permission. Alexandrov, A.W. (2012). Correlated anatomy,
pathophysiology and clinical examination, Association of Neurovascular Clinicians core
curriculum for neurovascular nursing. Health Outcomes Institute, Inc., Fountain Hills,
Arizona, p. 42.
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•
•
•

A missing single A1 segment of the ACA, with the remaining A1 segment
supplying blood to both the ipsilateral A2 segment as well as the contralateral A2
ACA segment via the AcomA;
A missing P1 segment of the PCA, with the PcomA supplying blood flow to the
P2 PCA segment (referred to as “fetal origin of the PCA”); or,
A missing PcomA on one side.

Relating Neurologic Findings to Arterial Distribution
A complete neurological assessment is essential in all acute stroke patients. It
must be performed quickly to collect assessment data and to assign specific suspect
arterial territories in under a minute or, decide if findings do not follow a discreet
territory, such as large intracranial hemorrhages that may cross arterial distributions or,
identify findings that are highly suspicious for a large number of stroke mimic diagnoses.
Table 2-1 presents findings aligned by vascular territories, anatomical structures, and
assessment items on the National Institutes of Health Stroke Scale (NINDS, 2011).
The NIHSS (Table 2-2) was originally developed for clinical trials of reperfusion
therapies in acute ischemic stroke (Lyden, 2017) and provides a structured method to
tailor the neurologic assessment in a manner that allows practitioners to collect pertinent
data and assign a score (Brott et al., 1989a; 1989b; Lyden et al., 1994). The NIHSS has a
bias for left hemisphere MCA territory stroke in that 7 total points require intact language
skills, so that left MCA stroke patients generally will have much higher NIHSS scores
than patients with right MCA territory strokes of equal infarct size (Woo et al., 1999).
Despite this bias, the NIHSS is widely acknowledged to be the gold standard (Lyden,
2017) for ischemic stroke patient assessment; therefore, mastering use of this instrument
is a prerequisite for acute stroke nurses (Goldstein & Samsa, 1997). While the Glasgow
Coma Scale (GCS) has been widely used as a neurologic assessment measure, the scale
was originally developed as a level of consciousness (LOC) measure to prognosticate
outcome in patients with traumatic brain injury (Nye et al., 2012; Teasdale & Jennett,
1974). Additionally, GCS scores require recording the patient’s “best response,” so that in
a stroke patient with normal LOC, the disabled side would not be scored if the tool were
used correctly. In other words, despite being highly disabled, it is likely that a GCS may
correctly score a patient as normal (score of 15) (Nye et al., 2012). Use of modified
versions, or what have been called “slim” versions, of the NIHSS has been shown to be
unacceptable by stroke nurses in that these scales may not capture the arterial territory
affected by stroke, thereby giving false reassurance that a patient is not disabled when
disability actually exists (Nye et al., 2012). Therefore, the evidence-based
recommendation widely accepted today is use of the full NIHSS, with use of just the
NIHSS elements that are positive for the disability used during more frequent
assessments for patients treated with alteplase tissue plasminogen activator (tPA) (Nye et
al., 2012; Middleton et al., 2015). Recently, the NIHSS has been validated for use in
patients with intraparenchymal hemorrhage (Dusenbury et al., 2019).
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Table 2-1.
Lobe/
Location
Frontal lobe

Parietal lobe

Temporal lobe

Occipital lobe

Clinical Localization of Stroke
Function

Circulation

Neurovascular
Territory
Cerebral Cortex (Telencephalon)
Voluntary motor function
Anterior
ACA
Brodmann’s Area 4
(Superiormedial aspect)
MCA
(lateral and
inferior
aspects)

Broca’s area
Brodmann’s Area 44
• Expressive language (ability to
name objects)
Cognitive function
Brodmann’s Areas 9-11
• Orientation
• Memory
• Judgement
• Arithmetic
• Abstract thinking
Primary somesthetic sensory
assessment
Brodmann’s Areas 1-3
• Pinprick
• Vibration
• Position sense
• Temperature
• Touch
Somesthetic association of external
stimuli spatial attention
Brodmann’s Areas 5, 7
• Double simultaneous stimulation
• Stereognosis
• Graphesthesia
Wernicke’s Area
Brodmann’s Areas 37, 39, 40
• Receptive language
Primary Auditory
Brodmann’s Area 41

Primary visual
Brodmann’s Area 17
Visual association
Brodmann’s Area 18

MCA (usually
left)
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• Leg weakness NIHSS Item 6
• Facial weakness
Central Cranial Nerve VII
NIHSS Item 4
• Dysarthria (slurred speech)
NIHSS Item 10
• Dysphagia (difficulty
swallowing)
Central IX & X Nerves
• Arm weakness
NIHSS Item 5
• Expressive Aphasia (inability
to express language)
NIHSS Item 9

ACA

• Orientation
NIHSS Items 1B & 1C;
influenced by NIHSS Item 9

ACA
(Superiormedial aspect)
MCA (lateral
and inferior
aspects)

• Tactile Sensation
(discrimination of pinprick)
NIHSS Item 8

MCA (usually
right)

• Neglect assessment (double
simultaneous stimulation,
tactile and visual)
NIHSS Item 11

MCA (usually
left)

• Receptive (Wernicke’s or
fluent) aphasia
NIHSS Item 9
• Hearing loss; uncommon
finding, generally not tested
unless evident with sudden
onset; central cranial nerve
VIII
Not represented on NIHSS
• Vision; peripheral visual
fields; differentiation between
monocular and binocular
lesions
NIHSS Item 3

MCA

Posterior

Common Pathologic Findings

PCA – Cortical
vision
MCA – Visual
pathways
OA –
monocular
blindness

Table 2-1. Continued
Lobe/
Location

Function

Circulation
Subcortex
Anterior

Anterior, lateral
and inferior
white matter
tracks

•
•

Motor relay
Sensory relay

Basal nuclei

•
•
•

Symmetrical rhythmic movement
Suppresses muscle tone
Influences postural adjustments

Anterior

Posterior-lateral
white matter
tracks

•
•

Motor relay
Sensory relay

Posterior

Thalami

•

Relay of all sensory transmission
except olfaction

Posterior

Neo-cerebellum
(middle vermis,
cerebellar
hemisphere)

•

Archi-cerebellum
(Flocculonodular lobe)

•

Projects fibers to the cerebral
cortex through the thalamus;
plays a role in planning and
initiation of movements and
regulating fine limb movement
Processes impulses from the
vestibular apparatus of the inner
ear to maintain equilibrium,
balance and posture
Multiple connections with the
ocular centers to facilitate eye
movement in response to postural
changes
Referred to as the spinocerebellum because it receives input
primarily from the spinal cord;
plays a role in control of muscle
tone and axial limb movements

•

Paleo-cerebellum
(anterior lobe
vermis, paramids, uvula,
para-flocculus)

•

Midbrain
(Mesenephalon)

•
•
•
•

Cell bodies for CN III & IV
◦ Pupillary constriction
◦ Eye movement
Level of consciousness
(ascending reticular formation)
Ascending sensory tracts
Descending motor tracts

Cerebellum
Posterior

Neurovascular
Territory
ACA
MCA
Lenticulostriate
perforators
MCA
Lenticulostriate
perforators
PCA
Thalamogeniculate
perforators
BA
PCA
Thalamogeniculate
perforators

Common Pathologic
Findings
• Pure motor loss
NIHSS Items 4-6
• Pure sensory loss
NIHSS Item 8
• Mixed motor and sensory loss
NIHSS Items 4-6 and 8
• Pure motor deficit
NIHSS Items 5, 6
• Pure motor loss
NIHSS Items 4-6
• Pure sensory loss
NIHSS Item 8
• Mixed motor and sensory loss
NIHSS Items 4-6 and 8
• Thalamic pain syndrome
NIHSS Item 8
• Pure sensory loss
NIHSS Item 8

BA
SCA
AICA

• Ataxia and gait disturbances
NIHSS Item 7
• Dysarthria (slurred speech)
NIHSS Item 10

Posterior

BA
AICA

• Vertigo, nystagmus
Not represented on NIHSS

Posterior

PICA
BA
AICA

• Ataxia and gait disturbances
NIHSS Item 7
• Dysarthria (slurred speech)
NIHSS Item 10

PCA
PcomA
Thalamogeniculate
perforators
Anterior and
posterior choroidal arteries
SCA
BA

• Pupillary dilation
Not represented on NIHSS
• EOM dysfunction
NIHSS Item 2
• Diplopia
Not represented on NIHSS
• Top of the basilar syndrome
with cortical blindness
NIHSS Item 3
• Decreased LOC
NIHSS Item 1
• Motor/sensory pathway
disruption
NIHSS Items 4-6 and 8

Brainstem
Posterior
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Table 2-1. Continued
Lobe/
Location
Pons
(Metencephalon)

Function
•

•
•
•
•
•

Medulla
oblongata
(Mylencephalon)

•
•
•
•
•
•
•

Circulation

Cell bodies for CN V-VIII
◦ Facial sensation & jaw clench
◦ Eye movement
◦ Facial expression
◦ Auditory reception & balance/equilibrium
Pneumotaxic center
Apneustic center
Level of consciousness
(ascending reticular formation)
Ascending sensory tracts
Descending motor tracts

Posterior

Cell bodies of CN IX-XII
Cardiac center
Vasomotor center
Respiratory center
Level of consciousness
(ascending reticular formation)
Ascending sensory tracts
Descending motor tracts

Posterior

Neurovascular
Territory
SCA
Pontine paramedian perforators
AICA
Internal auditory artery
BA

PICA
VA
ASA

Common Pathologic Findings
• Facial sensation
NIHSS Item 8
• Gaze palsies
NIHSS Item 2
• Diplopia
Not represented on NIHSS
• Facial droop
NIHSS Item 4
(Note: May present with
bilateral symptoms, whereby
the facial droop is ipsilateral
to the pontine infarction and
the limb weakness is contralateral to the infarction.)
• Hearing loss; cranial nerve
VIII; uncommon finding,
generally not tested unless
evident with sudden onset
Not represented on NIHSS
• Decreased LOC
NIHSS Item 1
◦ Locked-in syndrome
• Motor/sensory pathway
disruption
NIHSS Items 4-6 and 8
• Respiratory arrest or insufficiency
Not represented on NIHSS
• Dysphagia
Not represented on NIHSS
• Tongue deviation
Not represented on NIHSS
• Decreased LOC
NIHSS Item 1
• Cardiopulmonary instability
Not represented on NIHSS
• Vasomotor instability
Not represented on NIHSS
• Sensory/motor pathway
disruption
NIHSS Items 4-6 and 8

ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral
artery; OA, ophthalmic artery; AICA, anterior inferior cerebellar artery; VA, vertebral
artery; LOC, level of consciousness.
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Table 2-2. NIH Stroke Scale
Category
1a Level of Consciousness

Description

0=Alert
1=Arousable by Mild Stimulation
2=Obtunded/Arousable to Pain
3=Unresponsive/Reflex Only
1b Questions (Month and Age) 0=Answers Both Correctly
1=Answers One Correctly
2=None are Correct
1c Follows commands
0=Performs Both Correctly
1=Performs One Correctly
2=Performs Neither Correctly
2 Best Gaze
0=Normal
1=Partial Deviation
2=Forced Deviation
3 Visual Fields
0=No Visual Loss
1=Partial Hemianopia
2=Complete Hemianopia
3=Complete Hemianopia/Blind
4 Facial Palsy
0=Normal
1=Minor
2=Partial
3=Complete
5a Motor Left Arm
0=No Drift
1=Drift
2=Some Effort Against Gravity
3=No Effort Against Gravity
4=No Movement
5b Motor Right Arm
0=No Drift
1=Drift
2=Some Effort Against Gravity
3=No Effort Against Gravity
4=No Movement
6a Motor Left Leg
0=No Drift
1=Drift
2=Some Effort Against Gravity
3=No Effort Against Gravity
4=No Movement
6b Motor Right Leg
0=No Drift
1=Drift
2=Some Effort Against Gravity
3=No Effort Against Gravity
4=No Movement
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Table 2-2.

Continued

Category
7 Limb Ataxia

8 Sensory

9 Best Language

10 Dysarthria

11 Extinction/Inattention

Description
0=Absent
1=Present in One Limb
2=Present in Two Limbs
UN=Amputation or Joint Fusion
0=Normal
1=Mild to Moderate Loss
2=Severe to Total Loss
UN=Amputation or Joint Fusion
0=No Aphasia
1=Mild to Moderate Aphasia
2=Severe Aphasia
3=Mute, Global Aphasia
0=No Abnormality
1=Mild to Moderate
2=Severe
UN=Intubated or Physical Barrier
0=No Abnormality
1=Extinction to One Modality
2=Extinction to > 1 Modality

Data Source: National Institute of Neurological Disorders, Know Stroke
Campaign—NIH Stroke Scale. (n.d.). Retrieved July 30, 2019, from
https://www.stroke.nih.gov/resources/scale.htm
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Level of Consciousness (NIHSS Item 1)
Evaluation of level of consciousness (LOC) involves determining the degree of
wakefulness in a patient and makes up one of the most important elements of the
neurologic exam as it is a sensitive indicator of neurologic change (Dávalos et al., 1999).
Descriptors commonly used for LOC include alert (wide awake), lethargic (sleepy, dull,
indifferent), obtunded (deep sleep; difficult to arouse), stupor (unarousable, yet with
normal response [withdrawal or localization] to noxious stimuli), or comatose
(unarousable with abnormal response [mass response or absent response] to stimuli
(Tindall, 1990; Fisher, 1969). Evaluation of LOC is included in NIHSS items 1a
(wakefulness measure), 1b (responsiveness to questions), and 1c (responsiveness to
commands). Generally, patients suffering anterior circulation ischemic stroke will have a
normal LOC, with the exception of catastrophic bilateral anterior circulation lesions
(National Institutes of Health, 2011); this situation may remain true throughout the course
of stroke completion with the exception of a larger MCA stroke that is subject to severe
or even malignant edema that sets in and worsens within 24-28 hours after completed
infarction (Hacke et al., 1996). Posterior circulation strokes are generally at greater risk
of LOC deterioration―in particular brainstem strokes with disruption of ascending
reticular formation and those affecting the cerebellum, which may cause brainstem
compression and ventricular system obstruction (Brazis et al., 2016).
Cranial Nerve Examination
Twelve pairs of cranial nerves (CN) that are generally classified as part of the
peripheral nervous system; however, this is anatomically inaccurate in that CN II
originates from the central nervous system (Alexandrov, 2012). A detailed description of
CN anatomy and assessment would require a manuscript by itself but suffice it to say that
CN I and III-XII are considered true peripheral nerves, whereas CN II (optic nerve) is
derived from the optic stalks of the diencephalon composed of retinal ganglion cell axons
and glial cells, and similar to other axons of the central nervous, covered with myelin.
Assessment of CN I (olfactory), which originates in the forebrain, is generally deferred,
whereas assessments of CNs II-VII which have their cell bodies in the brainstem, are
incorporated within the NIHSS (Table 2-1) with the exception of pupillary constriction to
light, which can be added in the case of altered LOC or findings consistent with palsies of
CNs affecting extraocular movement (CN III, IV, and VI) (Alexandrov, 2012; Brazis et
al., 2016; ). CNs IX, X, and XII make up important components of stroke patient
assessment in that swallow integrity is insulted in about 50% of stroke patients (Aviv et
al., 1996; Martino et al., 2005). Swallow assessment will not be discussed in this paper
but often involves a comprehensive battery of tests starting with a clinical bedside screen,
assessment of LOC, which must be assessed to ensure adequate intake and airway
protection, and fiberoptic endoscopic evaluation of swallow (FEES) completed by a
speech and language pathologist (Donovan Neila J. et al., 2013). Additionally, insults to
CN VII, IX, and/or XII may also affect speech articulation resulting in a dysarthric
quality that may significantly limit communication. Assessment of CN XI (spinal
accessory) can be easily incorporated into a neurologic exam through the addition of
shoulder shrug and head turning (Walker, 1990). Cranial nerve VIII (vestibulocochlear) is
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rarely tested unless the patient presents with stroke symptoms accompanied by a sudden
onset acute hearing loss or acute onset of vertigo. When this is the case, suspicion of
brainstem infarction should remain high, especially when accompanied by other
brainstem findings, although temporal lobe infarction may be a consideration (Bamiou,
2015).
Extraocular Movement (NIHSS Item 2). Assessment of EOMs provides the
examiner with information reflective to brainstem integrity and level of brainstem
dysfunction given that the cell bodies of these nerves originate in the midbrain (CN III
and IV) and pons (CN VI) (Leigh & Zee, 2006). Classically, the patient is asked to move
their eyes to trace the movement of the examiner’s fingers―generally in an “H”
configuration―whereas the NIHSS asks the patient to trace the examiner’s fingers
through lateral eye movement (National Institutes of Health, 2011). In the case of altered
LOC, oculocephalic maneuver, or doll’s eyes, are examined and an absence of full
movement indicates brainstem dysfunction (Strupp et al., 2014). In a conscious patient
that is unable to understand what the examiner requests, the examiner should move about
the patient to draw eye movement in their direction so EOMs can be evaluated (NINDS
Know Stroke Campaign - NIH Stroke Scale, n.d.).
Findings from EOM testing must be differentiated from findings associated with
the frontal eye fields (between Brodmann’s areas 4, 6, and 8, by the middle frontal and
precentral gyri; Figure 2-1). The frontal eye fields are responsible for saccadic eye
movements that normally allow the eyes to move rapidly together to surveil visual
content; interruption of this area of the brain causes conjugate eye deviation toward the
affected MCA territory (Trobe, 2001). In contrast, brainstem CN III, IV, and VI findings
include either lateral deviation, ptosis and pupillary dilation (CN III; oculomotor), or loss
of superior oblique innervation with upward migration and vertical diplopia that worsens
when attempting to look down (CN IV; trochlear), or midline eye deviation with limited
lateral gaze producing diplopia (CN VI; abducens) (Strupp et al., 2014). With significant
brainstem destruction, patients may present with fixed gaze in combination with other
classic brainstem findings such as decreased LOC, including coma (Pula & Yuen, 2017).
Peripheral Vision, (NIHSS Item 3). Peripheral vision (CN II) is assessed by
evaluating each eye independently and both eyes collectively (National Institutes of
Health, 2011). Vision for each eye is divided into four quadrants and visual loss is
determined to be either monocular (resulting from pre-chiasmal stroke affecting the retina
or optic nerves) or binocular (stroke at or posterior to the chiasm) (Brazis et al., 2016).
The more posterior along the visual tracts that the stroke occurs, the more congruent the
deficit is in each eye (Brazis et al., 2016; Kedar et al., 2011). Visual field loss can be
affected by ophthalmic artery (monocular), MCA (binocular), PCA (binocular) or top of
the BA (binocular, including bilateral hemianopia – also referred to as cortical blindness)
stroke (Pula & Yuen, 2017). In the case of MCA stroke producing visual loss, the
examiner should expect vision loss to also be accompanied by findings classically
associated with MCA stroke such as voluntary motor and/or primary sensory loss,
aphasia (usually left hemisphere), and/or neglect (usually right hemisphere) (Pula &
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Yuen, 2017; Rowe et al., 2013), whereas in pure P2 PCA stroke, the examiner would
expect binocular hemianopia without other disability findings (Cereda & Carrera, 2012).
To evaluate visual fields, the examiner assesses the patient’s ability to visualize
an object (usually the examiner’s fingers) in each of the four quadrants of vision. While
some NIHSS training films demonstrate this assessment by asking the patient to state
how many fingers they see in each field, this often leads to confusion. For example, if the
patient says “2 fingers” when 3 fingers were actually held up, some examiners miss score
this as visual field loss; however, the patient did in fact see the examiner’s fingers, so
vision should be assumed to be intact. The error in this example may actually be on the
part of the examiner through failure to accurately position fingers within the patient’s
visual field. Therefore, it is often clearer to just simply have the patient state “now” when
they see the examiner’s finger start wiggling in each quadrant. But by far the most
common error made by novice examiners is holding their arms/fingers too far into the
periphery for the patient to see. Examiners must remember to use themselves as
confirmation and make sure that their fingers are held well within a field of vision that is
easily seen to avoid assuming visual loss in a patient that has normal visual fields. For
patients unable to participate in this exam due to altered LOC, cognitive or language
dysfunction, blinking to threat will suffice as confirmation of intact vision (Trobe, 2001).
Facial Symmetry (NIHSS Item 4). Nervous control of facial expression arises
from the corticobulbar fibers that originate on the lower lateral side of the precentral
gyrus (Figure 2-1; Brodmann’s area 4; MCA territory), coursing through the corona
radiata, internal capsule, and medial cerebral peduncle to the pons, where most fibers
decussate and then terminate in the contralateral facial motor cell body (Brazis et al.,
2016). Stroke affecting the MCA territory interferes with precentral gyrus trans-mission,
producing what is often referred to as “central VII” motor loss, whereas brainstem stroke
at the site of the pontine CN VII nucleus results in loss of peripheral facial innervation.
With central VII loss, the upper face is commonly spared, and there are several
physiologic theories explaining this preserved function, including bilateral supranuclear
control and the scant direct cortical innervation provided to the upper face. Therefore,
loss of the upper face is expected to occur most commonly with brainstem pontine stroke
and is considered uncommon in MCA distribution stroke (Brazis et al., 2016; Terao et al.,
1997). Symmetric facial expression (CN VII) is assessed by asking the patient to smile,
blow out the cheeks, close the eyes tightly, and raise the eyebrows (National Institutes of
Health, 2011). Dysarthria, or slurred speech (NIHSS item 10), is commonly found in
relation to motor loss affecting the lower face. Expected findings align with vascular
territories as follows:
•
•

MCA stroke―Flattening of the nasolabial folds on the same side as limb
weakness (Brazis et al., 2016)
BA distribution stroke―
o Upper brainstem―Coextensive (face, arm, leg) contralateral weakness in
relation to the infarction, or
o Lower pontine―Facial droop ipsilateral to the pontine infarction with limb
weakness contralateral to pontine infarction.
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With extremely rare exceptions caused by discreet medullary stroke lesions
(Dejerine’s Anterior Bulbar (Brazis et al., 2016; Kumral et al., 2002) [medial medullary]
syndrome or pure Wallenberg [lateral medullary] syndrome that excludes Opalski
(Montaner & Alvarez-Sabín, 1999) [submedullary] components), examiners should be
highly suspect of presentations involving motor loss of the limbs with sparing of the face,
as this presentation may suggest a stroke mimic diagnosis. Completion of emergent
magnetic resonance imaging (MRI) diffusion weighted imaging (DWI)/apparent
diffusion coefficient (ADC) and fluid attenuated inversion recovery (FLAIR) sequences
will immediately confirm or dispel stroke diagnosis with such a presentation (Kim et al.,
2014).
Motor Examination
The motor homunculus, Latin for “little man” (Figure 2-4), is a graphic depiction
of what a man would look like if the body parts were proportionate to the amount/size of
brain territory on the precentral gyrus (Figure 2-1; Brodmann area 4) dedicated to
specific types of motor function. The most superior and medial areas of the precentral
gyrus control voluntary movement for the lower extremities. Progressing laterally and
inferiorly, the homunculus distribution includes the trunk, arm, hand, face, lips, tongue,
and larynx. When considering the layout of the motor homunculus in relation to the
anterior circulation’s distribution, the ACA supplies blood flow to the areas of the
precentral gyrus that innervate voluntary motor function in the lower limbs, whereas
MCA distribution supplies blood flow to areas on the gyrus responsible for innervation of
the arms, facial, and orolingual structures. For this reason, MCA distribution strokes
commonly present with similar motor loss in the face and arm. The more distal the MCA
occlusion, leg involvement may be entirely spared, whereas in distal ICA/proximal MCA
stroke near in proximity to the ACA A1 division (Figure 2-2), patients may present with
face, arm, and leg motor loss (Brazis et al., 2016).
A large portion of the corticospinal tract originates in the precentral gyrus and
descends through the internal capsule into the brainstem, where most motor fibers
decussate in the pyramids of the medulla before descending to the spinal cord and lower
motor neurons. In this way, the right and left precentral gyri control voluntary motor
function for the opposite side of the body. Stroke that interferes with the descent and
distribution of the corticospinal tract within the cortex, subcortex, or brainstem will cause
voluntary limb motor loss on the opposite side of the body. Opalski syndrome complicating a Wallenberg presentation is a rare exception in that motor extremity loss is
ipsilateral to the medullary stroke (Brazis et al., 2016).
Motor function is classically graded using a muscle strength scale of 0 to 5, where
0 equals no movement and 5 equals normal power (Table 2-3) (Brazis et al., 2016).
Findings are presented as a fraction with the patient’s actual muscle strength in the
numerator and normal muscle strength (grade 5) in the denominator. Motor function is
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Figure 2-4. Motor Homunculus
Reprinted with permission. Alexandrov, A.W. (2012). Correlated anatomy,
pathophysiology and clinical examination, Association of Neurovascular Clinicians core
curriculum for neurovascular nursing. Health Outcomes Institute, Inc., Fountain Hills,
Arizona, p. 44.

Table 2-3.

Muscle Strength Grading Scale

Numeric Value
Grade
0
No muscle activation
1
Trace muscle activation, such as a twitch, without achieving full
range of motion
2
Muscle activation with gravity eliminated, achieving full range of
motion
3
Muscle activation against gravity, full range of motion
4
5

Muscle activation against some resistance, full range of motion
Muscle activation against the examiner’s full resistance, full range of
motion

Data Source: Williams M. Manual muscle testing, development and current use. Phys
Ther Rev. 1956 Dec;36(12):797-805.
https://doi.org/10.1093/ptj/39.7.466.PMID:13667456
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also measured on the NIHSS in Item 5 (motor arm) and Item 6 (motor leg) (Williams,
1956). The number assigned on the NIHSS should not be confused with the motor grade
in that the NIHSS is a scale whose numeric values add weight to connotate severity on an
ordinal scale.
Ataxia is a disturbance of the smooth performance of voluntary motor function,
resulting in errors in movement timing, force, range, and speed (Ashizawa & Xia, 2016).
Stroke affecting the cerebellum results in motor function without inhibition and
modulation producing inaccurate and inconsistent movement (Wright et al., 2014).
Ataxia is tested on the NIHSS (item 7) using the finger–nose–finger and heel–shin tests.
The examiner has the patient reach using the full length of their arm to touch the
examiner’s finger; the examiner can move placement of the finger with each subsequent
reach by the patient, while observing for smooth, accurate movement. The heel–shin test
is performed with the patient laying on their back; the patient is asked to run their heel
down the shin of the opposite leg and back up again to the knee. The test is repeated in
both limbs while the examiner observes for smooth, accurate limb motion. Misinterpretation of ataxia findings is common. When motor weakness results in loss of coordination, ataxia should be scored as 0 on the NIHSS; however, when motor strength is normal
but movement lacks coordination, ataxia should be scored as present (National Institutes
of Health, 2011).
Sensory Examination
Sensory pathways ascend the spinal cord decussating either within the cord or the
brainstem before reaching the thalamus, where they are relayed to the parietal lobe’s
postcentral gyrus. The postcentral gyrus (Figure 2-1; Brodmann’s areas 1-3) houses the
primary somatosensory cortex and can be illustrated with a sensory homunculus whose
layout is distributed by the amount of gyrus brain tissue dedicated to various parts of the
body (Brazis et al., 2016).
Proprioception, a sensory function, has a conscious and an unconscious
component. The conscious pathway connects with the thalamus and the cerebral cortex,
enabling an understanding of the position of the body in space, while the unconscious
pathway connects with the cerebellum, facilitating walking and complex acts without
having to think about which joints to flex and/or extend. While proprioception is not
included as part of the NIHSS, it can be easily added to the neurologic exam when other
sensory findings are identified. The test is performed with the patient’s eyes closed; the
examiner then moves the patient’s finger up or down, right or left asking the patient the
direction the joint is moving (Brazis et al., 2016; Gilman, 2002).
Examination of primary sensory function on the NIHSS includes testing of touch
sensation on the face, arms, and legs. The examiner begins by touching the side that
appears unaffected by stroke with a pin and asking the patient if it feels “sharp;” the
examiner then moves to the affected side repeating the procedure and asking the patient if
it feels “as sharp” as the unaffected side. It is important to use a pin so that the patient can
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clearly discriminate the sensation, as use of touch alone may mask an actual sensory loss
(National Institutes of Health, 2011).
In general, the right hemisphere dominates in completion of tasks that require
non-visual spatial attention, especially in right handed persons (Becker & Karnath, 2007;
Bowen et al., 1999; Heilman et al., 2000). Attention activated by external stimuli is
localized to the inferior parietal lobe and the posterior aspect of the superior temporal
gyrus with the right hemisphere alerting both sides of the body (Brazis et al., 2016);
because of this, hemi-neglect syndromes are most commonly associated with right
parietal MCA lesions (Weintraub & Mesulam, 1987).
The NIHSS assessment of neglect (item 11) includes a tactile and a visuospatial
component. Tactile neglect is tested with the patient’s eyes closed to determine if they
can distinguish being touched simultaneously on each side. In the case of left hemineglect
syndrome, the patient is unable to consistently recognize simultaneous touch on the left
side of his/her body. The examiner touches one side of the face or both sides of the face
simultaneously with a brief on-off low pressure movement and asks the patient to state
which side was touched; the procedure is then repeated in the patient’s arms and if
necessary, legs. Visuospatial neglect is tested during assessment of NIHSS item 3 (to
avoid redundant eye testing) in patients with intact visual fields, and findings are
incorporated into the scoring of neglect on item 11. The examiner positions his/her
fingers within the visual fields of both the patient’s eyes; most commonly the examiner
asks the patient to state which finger is wiggling – right, left, or both – starting first by
wiggling a finger on one hand, then the other hand, and then providing double
simultaneous stimuli by wiggling a finger on both hands at the same time. Patients with
hemineglect may present with only tactile or visuospatial neglect, or they may present
with profound neglect where both tactile and visuospatial attention is affected (Brazis et
al., 2016; National Institutes of Health, 2011; Ellis & Small, 1993).
Language Examination
Language is considered a sensorimotor function of the brain in that it requires
functions tied to receiving and processing language (sensory) as well as language
expression (motor) (Brazis et al., 2016). In general, the left hemisphere of the brain
houses language and linguistic functions, along with other executive functions such as
mathematical skills, reasoning, and analysis (Brazis et al., 2016). Aphasia is the inability
to comprehend or formulate language (Damasio, 1992) and is tested by NIHSS item 9
(National Institutes of Health, 2011). Motor language aphasia produces expressive loss
due to frontal cortical MCA stroke in Broca’s area (Broca, 1865) (Figure 2-1;
Brodmann’s area 44), and is tested through examination of language fluency on the
NIHSS by asking the patient to name items and describe a scene (Mohr et al., 1978).
Sensory language aphasia produces an inability to receive language due to MCA stroke in
Wernicke’s area (Figure 2-1; Brodmann’s area 37, 39, and 40), resulting in inability to
assemble phonemes accurately, inability to repeat sentences correctly, and inability to
name items correctly (Wernicke, 1974; Wilkins & Brody, 1970). However, compared to
patients with Broca’s aphasia, those with Wernicke’s aphasia have effortless, yet
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difficult-to-decipher speech, and therefore this type of disability is often described as
“fluent aphasia” (Turkstra, 2011). NIHSS item 9 assesses receptive deficits by examining
language fluency as the patient describes pictures and reads sentences. The examiner can
also attempt to engage the patient in conversation to further differentiate aphasia type.
Global aphasia presentations are associated with large left MCA stroke, often presenting
with perisylvian lesions that produce both Wernicke and Broca aphasia components,
leaving the patient mute and with impaired comprehension (Damasio, 1992).

Summary
A thorough and precise neurological examination is essential for rapid diagnosis,
treatment, and ongoing evaluation of acute stroke patients. Although challenging,
practice and repetition, alongside a commitment to furthering knowledge of neurologic
anatomy and physiology, are the key to examiner proficiency and expertise. Subtle
neurologic changes requiring immediate intervention often can only be identified through
completion of serial assessments. Since stroke evolves over minutes and even days,
nurses caring for acute stroke patients must seek to master assessment skills with an eye
to the vascular territory affected to reduce significant risks for devastating disability,
deterioration, and death.
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CHAPTER 3. VALIDATING THE NATIONAL INSTITUTES OF HEALTH
STROKE SCALE IN INTRACEREBRAL HEMORRHAGE

Introduction
Intracerebral hemorrhage (ICH) is a catastrophic event associated with high
mortality and morbidity (Kim & Bae, 2017), carrying a fatality rate of approximately
40% at one month and 54% at one year (An et al., 2017). Early hematoma expansion
occurs in up to 40% of ICH patients (Dowlatshahi et al., 2011; Ovesen et al., 2014; Yu et
al., 2017) and is independently associated with early neurological deterioration (Brott et
al., 1997; Leira et al., 2004), poor functional outcome, and death (Davis et al., 2006;
Delcourt et al., 2012). Only12-39% of surviving ICH patients achieve long-term
functional independence (An et al., 2017). Despite the devastating nature of this disease,
debate remains as to what neurologic assessment tool would best support the initial
examination for early prognostication.
The ICH Score (Hemphill et al., 2001) was developed as a prognostic tool using
predictors of poor clinical outcome such as hematoma volume, location, patient age, and
level of consciousness (LOC). However, the ICH score itself lacks utility as a measure of
neurologic disability. Clinical assessment of ICH is most commonly done with the
Glasgow Coma Scale (GCS) (Teasdale & Jennett, 1974), but as a level of consciousness
tool, the GCS also lacks details of focal neurologic findings. The National Institutes of
Health Stroke Scale (NIHSS) (Brott et al., 1989) has been validated as a measure of
ischemic stroke severity (Mustanoja et al., 2015) as well as an ischemic stroke outcome
predictor (Cheung & Zou, 2003; D’Olhaberriague Luis et al., 1996; Lyden & Lau, 1991).
Use of the NIHSS in ICH patients may provide a more detailed picture of stroke severity
and neurological disability than the GCS alone (Fonarow et al., 2012; Smith et al., 2010).
Therefore, we sought to examine the utility of the admission NIHSS in comparison to the
GCS to discriminate early poor functional outcome at 24 hours and hematoma volume in
a prospective cohort of ICH patients.

Methods
Institutional Review Board (IRB) approval was obtained for a prospective registry
of hospital data on acute ICH patients admitted to a tertiary care comprehensive stroke
center (CSC) in the Mid-South region of the United States stroke belt. We included in our
sample consecutive adult patients (≥18 years of age) over a 5-year period with
spontaneous ICH with last known well within 24 hours of CSC hospital admission. We
excluded patients with ICH due to trauma, brain tumors, venous sinus thrombosis, and
ICH from underlying structural vascular lesions. All ICHs were initially admitted to the
neuro-intensive care unit (NICU). As per hospital protocol, patients were treated with
intravenous antihypertensive agents to reach a goal systolic blood pressure (SBP) <140
mmHg during the first 24 hours after admission. SBP goal <160mmHg was used in

27

patients with admission SBP >220 mmHg and acute kidney impairment. Stability head
CT scans were obtained at 6 hours post admission as standard of care.
De-identified patient data were collected prospectively, including both GCS and
NIHSS assessments alongside demographics, 24 hour Modified Rankin Score (mRS),
neuroimaging findings (including calculation of hematoma volume), presence of
intraventricular hemorrhage, bleed location, and hospital discharge outcomes. Hematoma
volume was calculated using the (AxBxC)/2 method and bleeds >30 cm3 were classified
as large hematoma volume. Modified Rankin Scores at 24 hours were dichotomized to
good functional outcome (mRS 0-2) and poor functional outcome (mRS 3-6).
Data were entered and analyzed with SPSS (IBM version 25). Data are presented
as mean ± standard deviation or median with interquartile range (25th–75th percentile), if
not normally distributed. We evaluated the predictive ability of NIHSS and GCS scores
for detection of poor functional outcome at 24 hours and large hematoma volumes using
receiver operating characteristic (ROC) curve models. Areas under receiver-operator
curves (c statistic) and corresponding 95% confidence intervals (CIs) were calculated as a
measure of predictive ability. The c statistic integrates sensitivity and specificity of the
range of a variable and estimates how well a prediction rule can correctly rank-order
patients by risk. Ideal prediction produces a c statistic of 1.00; prediction no better than
chance is associated with a c statistic of ≤ 0.50. The c statistics of NIHSS and GCS scores
for predicting poor functional outcome at 24 hours and large hematoma volumes were
compared using the DeLong test (DeLong et al., 1988). The correlation of NIHSS and
GCS scores was evaluated by Spearman correlation.

Results
A total of 672 ICH patients were included: Mean age 62±14 years; 56% men,
58% African American, 41% White, and 22% were of Latino ethnicity (Table 3-1).
Common comorbidities included hypertension (86%), diabetes (35%), active cigarette
smoking (34%), and hyperlipidemia (32%), with 26% taking statin medications, 32% on
antiplatelet medications, and 4% on anticoagulant medication.
Overall, median ICH score for the cohort was 1 (IQR 0-2) with a median ICH
volume of 7 cm3 (IQR 2-18 cm3) on admission CT. The majority (34%) of hemorrhages
were in the basal ganglia and 14% were infratentorial. Forty-five percent of patients had
intraventricular extension and 17% of patients had hemorrhage volume expansion on 6
hour post admission stability CT scans or repeat CT scans for clinical deterioration within
the first 24 hours of ictus.
Median admission NIHSS was 8 points (IQR 2-18), and median admission GCS
was 15 points (IQR 7-15). Median 24-hour mRS was 4 (IQR 2-5), with 67.5% of the
sample having mRS-scores of 3 to 6. The admission NIHSS showed a strong negative
correlation to the admission GCS (r=-0.773; p<0.001). The admission NIHSS (c statistic:
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Table 3-1.

Sample Characteristics

Characteristics
Sex:
Male
Female
Age
Race:
White
African American / Black
Asian
Other
Latino Ethnicity
Hypertension
Active Smoker
Diabetes
Admission Hemoglobin A1c
Hyperlipidemia
Statin Medication
Antiplatelet Medication
Anticoagulation Medication
Admission INR
Body Mass Index
Location of ICH:
Basal Ganglia
Thalamus
Brainstem
Cerebellum
Lobar
Centrum Semiovale
Other
Admission Volume of ICH
Intraventricular Hemorrhage
24 hr Hematoma Expansion
ICH Score
Admission GCS Score
Admission NIHSS Score
mRS Score at 24 hr.
mRS 3 to 6 at 24 hr.
Length of Stay
Discharge Disposition:
Home
Inpatient Rehabilitation
Skilled Nursing/Long Term Care
Hospice
Died

Results
56%
44%
62 ± 14 (median 60 [IQR 52-72]) years
41%
58%
0.5%
0.5%
22%
86%
34%
35%
6.2 ± 1.7 (median 5.7 [IQR 5.3-6.4]) %
32%
26%
32%
4%
1.1 ± 0.37 (median 1.0 [IQR 1.0-1.1])
28.9 ± 7.4 (median 27.5 [23.7-32.6]) kg/m2
34%
19%
6%
8%
30%
1%
2%
14.2 ± 18.1 (median 7.0 [IQR 2.3-18.4]) cm3
45%
17%
Median 1 (IQR 0-2)
Median 15 (IQR 7-15)
Median 8 (IQR 2-18)
Median 4 (IQR 2-5)
67.5%
10.1 ± 11.2 (median 6 [IQR 3-12]) days
30%
27%
16%
3%
24%

INR, International Normalized Ratio; ICH, Intracerebral hemorrhage; GCS, Glasgow
Coma Scale
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0.91; 95% CI: 0.89-0.93) discriminated better than admission GCS (c statistic: 0.78; 95%
CI: 0.75-0.81) for 24 hour poor mRS (DeLong test p<0.001; Figure 3-1A). The
admission NIHSS (c statistic: 0.82; 95% CI: 0.78-0.86) also discriminated better than
GCS (c statistic: 0.78; 95% CI: 0.73-0.83) for large hematoma volume (DeLong test
p=0.029; Figure 3-1B). Thirty percent of patients were discharged home, while 24% died
during admission.

Discussion
Our findings indicate that the admission NIHSS is a better discriminator for large
admission hematoma volume and poor functional status at 24 hours than the GCS. Our
findings are not surprising, as others also have found that the NIHSS correlated strongly
with hematoma volume (Bae et al., 2000; Maas et al., 2015; Mohammed et al., 2019), and
hematoma volume is considered an important predictor of ICH outcome (Maas et al.,
2015). The ability of the NIHSS to discriminate hematoma volume better than the GCS
speaks well for the scale’s utility as an ICH clinical assessment measure. In addition to
level of consciousness, NIHSS’s additive prognostic value stems from measurements of
focal neurological deficits that could be further determinants of poor functional
outcomes. Because hematoma expansion is often associated with neurological
deterioration and poor clinical outcome (Davis et al., 2006; Mayer et al., 1994), the
ability to capture neurological deterioration beyond LOC would benefit patient
management, especially in the early hours following ICH ictus when hemorrhage
expansion is most likely. While the ICH Score is a widely used scale that has been
externally validated for outcome prognostication (Hemphill et al., 2015), its usefulness is
limited due to unsuitability for serial assessments and poor discrimination of spectrum of
functional outcomes beyond mortality (Nye et al., 2012).
The GCS was developed in 1974 as an assessment of the “depth” of impaired
consciousness in patients with acute cerebral disorders (Prasad, 1996). As a LOC
measure, use of the GCS has been favored historically for serial assessments in ICH
(Maas et al., 2015; Qureshi et al., 2001) since LOC (inversely related to hematoma
volume) is a key determinant to outcome. However, the GCS fails to provide the variety
of clinically important focal assessment data contained within the NIHSS. In our study
median, GCS was 15 (normal) since most patients were awake yet had sizeable
neurologic deficits. This limitation of the GCS has been noted previously in a substantial
number of acute stroke patients with measurable disabling deficits on the NIHSS and no
deficit on GCS (Nye et al., 2012).
Neurologic assessments are essential to understanding stability, improvement, and
deterioration in acute stroke patients (Finocchi et al., 2018), and while both GCS and
NIHSS are used in ICH patients (Demchuk et al., 2012; Vespa et al., 2005), consensus on
the use of a specific scale for baseline and serial assessment in ICH patients has been
lacking (Nye et al., 2012). The NIHSS is a potent predictor of outcome (Cheung & Zou,
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Figure 3-1. Receiver Operating Curve Analysis
ROC, receiver operating characteristic; GSC, Glasgow Coma Scale.
A: Receiver Operating Curve analysis of admission NIHSS and the admission GCS for
Modified Rankin Scores (mRS) at 24 hours from intracerebral hemorrhage ictus.
B: Receiver Operating Curve analysis of the admission NIHSS and the admission GCS
for intracerebral hematoma volume.
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2003; D’Olhaberriague et al., 1996; Lyden & Lau, 1991) and has been found to correlate
well with frequently used functional outcome scales such as the mRS and the Barthel
index (Lyden et al., 2001). The admission NIHSS has also been found to correlate with
functional outcomes after stroke (Cheung et al., 2008; Kazaryan et al., 2016;
(Mohammed et al., 2019). Decreased LOC on presentation has been thought to diminish
the utility of the NIHSS (Hemphill et al., 2015); however, prediction of ICH mortality
has been found to be better with the NIHSS than with GCS (Hosomi et al., 2009).

Limitations
Our work has limitations, including use of a single site for this study with
sampling obtained within one geographical region. We also recognize that there is
subjectivity within the NIHSS itself, and varying levels of competency between
examiners could potentially cause discrepancies in scoring (Hinkle, 2014). However, all
NIHSS scores in our study were obtained by highly experienced stroke and neurocritical
care physicians and nurse practitioners, all certified in use of the NIHSS. Lastly, our
work is limited to findings obtained during the early hospitalization period when ICH
worsening is most common, and as such, it does not address longitudinal morbidity and
mortality in our subjects. Despite this limitation, previous work has shown that early
NIHSS scores are predictive of 30-day and 5-year mortality as well as long-term
functional outcome in survivors (Cheung et al., 2008).

Conclusions
In conclusion, our study supports the use of NIHSS for the initial assessment of
acute ICH patients. This information can provide baseline measurement that is of
prognostic value to identify patients at risk of devastating neurologic disability (Brouwers
& Goldstein, 2012; Yu et al., 2017). While our study did not evaluate use of the NIHSS
as a serial measure in ICH, future work should explore this option as the NIHSS may
improve early recognition of neurological deterioration without a decrease in LOC as
well as mounting disability over time, enabling better prognostication and earlier
implementation of injury-reducing strategies.
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CHAPTER 4. INTERNATIONAL BELIEFS AND HEAD POSITIONING
PRACTICES IN PATIENTS WITH SPONTANEOUS HYPERACUTE
INTRAPARENCHYMAL HEMORRHAGE

Introduction
The optimal head position for various types of stroke may be important to ensure
clinical stability, especially in the hyperacute stage of management. The Head Position in
Stroke Trial (HeadPoST; Anderson et al., 2017) was a large cluster-randomized trial that
attempted to determine whether head position could affect three-month functional
outcome in both ischemic and intraparenchymal hemorrhagic (IPH) stroke. The trial
found no difference in outcomes between those managed with the head at 0- or 30degrees height. The methodology used and the conclusions drawn by HeadPoST
investigators have been heavily criticized for several reasons, including enrollment of
relatively minor stroke patients (National Institutes of Health Stroke Scale [NIHSS]
median score 4 [IQR 2-8] hours) that were many hours into stroke symptoms (median 14
[IQR 5-35] hours), unknown intervention fidelity, the potential for enrollment bias
particularly among the IPH cohort, lack of vascular imaging and serial clinical
monitoring, and use of a 3-month endpoint that had not been previously studied and
therefore lacked data to support an understanding of effect size for the intervention in
each of the patient populations enrolled (Alexandrov et al., 2018). Currently, it remains
unknown whether HeadPoST has resulted in clinical practice changes within either
hyperacute ischemic stroke or IPH cohorts, although a multi-site clinical trial is underway
in hyperacute large vessel occlusion (LVO) ischemic stroke patients to better examine the
effect of head position on clinical stability prior to thrombectomy (Zero Degree Head
Positioning in Hyperacute Large Artery Ischemic Stroke. ClinicalTrials.Gov, n.d.).
Few studies have explored head positioning in the hyperacute IPH population
using a serial monitoring approach to understand benefit or harm associated with the
intervention (Ali et al., 2017; Anderson et al., 2017; Aries et al., 2012; Favilla et al.,
2014; Hayashida et al., 1993; Hunter et al., 2011; Olavarría et al., 2014; Ouchi et al.,
2001; Palazzo et al., 2016; Saqqur et al., 2010; Schwarz Stefan et al., 2002; Wojner et al.,
2002; Wojner-Alexander et al., 2005). Unlike the majority of ischemic stroke patients,
increased intracranial pressure (ICP) may be a real concern in patients with IPH, although
reports of increased ICP vary significantly in this patient population (Chambers et al.,
2001; Diringer et al., 1998; Huttner et al., 2006; Huttner et al., 2007) and are likely driven
by hemorrhage volume, pre-existing intracranial capacity, and hemorrhage location.
Positioning the HOB at 30-degrees is recommended in current United States guidelines
(Hemphill J. Claude et al., 2015) and head elevation is theoretically sound (Feldman et
al., 1992; Kellie & Royal College of Surgeons of England, 1824; Kenning et al., 1981;
Lundberg, 1962; Magnaes, 1978; Mitchell & Mauss, 1978; Mitchell et al., 1981; Mokri,
2001; Ng et al., 2004; Rosner & Coley, 1986; Schneider et al., 1993) especially in the
absence of ICP monitoring where actual pressures are unknown. However, European,
Canadian, and Australian guidelines are silent on IPH head positioning (Shoamanesh et
al., 2021; Steiner et al., 2014; Stroke Foundation, (n.d)); We sought to understand
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whether clinical equipoise existed in selection of head position for patients with
hyperacute IPH in the years following publication of HeadPoST, and to identify methods
and endpoints that practitioners believed would best support a clinical trial of head
positioning in hyperacute spontaneous IPH.

Methods

Survey Aims
Institutional Review Board approval was obtained for the conduct of an
international, web-distributed survey focused on head positioning in hyperacute IPH
patients. The three main aims of the survey were: 1) to explore whether clinical
equipoise existed following publication of HeadPoST in selection of head positioning in
the hyperacute IPH population; 2) to determine what interdisciplinary practitioners
deemed to be the most appropriate primary endpoint and the timing for endpoint
measurement for future hyperacute IPH head positioning clinical trials; and, 3) to
determine what serial clinical monitoring parameters and/or device measurements
interdisciplinary practitioners deemed most important to definitively determine best head
position for hyperacute IPH patients.
Targeted Survey Participants
Investigator consensus was reached that a variety of IPH interdisciplinary
providers should be invited to complete the survey. We therefore targeted physicians,
bedside nurses, and advanced practice providers (APP) (i.e., nurse practitioners, clinical
nurse specialists, and physician assistants) since these providers were most likely to
assign/prescribe or assume responsibility for head positioning in hyperacute IPH patients.
Survey Design
An English-language-only survey was constructed with a brief, open-ended
demographics section limited to country of practice, years of post-graduate clinical
experience managing hyperacute IPH patients, annual hyperacute IPH patient volume,
profession and title of clinical position, prescriber status, and primary unit where the
respondent was employed or spent most time clinically (i.e., critical care, emergency, or
stroke unit). We deliberately did not collect any identifying information about the
hospital site or individual participants.
To understand uptake into practice of HeadPoST findings, we crafted the question
“Does your hospital have a policy or procedure that specifies placement of the head at
30o height in hyperacute IPH?” (Response options: Yes, No, Unsure). We also developed
a Likert scale item (1=strongly agree, 2=agree, 3=unsure, 4=disagree, and 5=strongly
disagree) to further understand use of standard admission orders for head positioning,
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namely, “Written admission orders for hyperacute IPH patients always include
positioning the head at 30-degrees elevation on my unit.”
Two Likert scale IPH “practice belief” survey items were also developed. These
items were accompanied by instructions stating clearly that there were no right or wrong
answers to these questions, instead emphasizing that we were interested in respondents’
“beliefs” about the items listed on the survey. The first practice belief item was focused
on the clinical equipoise aim of the study, asking respondents to rate their beliefs to the
statement “HeadPoST findings provide definitive evidence that head positioning
(elevated to 30-degrees or 0-degrees flat) does not matter in patients with hyperacute
IPH.” The second practice belief item was focused on beliefs associated with the validity
of head positioning as a method that could alone impact longitudinal patient outcomes: “I
believe that head positioning ALONE can influence 6-month outcomes in IPH.” Use of 6
instead of 3 months was selected for this item given data demonstrating that IPH
functional outcome is best measured at this point of time (De Wit et al., 2012; Hemphill
et al., 2009).
Given that international guidelines remain silent on head positioning, one survey
item was constructed to understand both the timing and preferred endpoint measures
recommended by participants for use in future hyperacute IPH head positioning clinical
trials. Specifically, respondents were asked to choose one of the following mutually
exclusive options: A) a proximal serial clinical stability endpoint using clinical measures
such as the serial NIHSS or the Glasgow Coma Scale (GCS) during the head positioning
intervention; B) available instruments such as serial ICP and/or brain tissue oxygenation
(PbtO2) monitoring in combination with clinical measures (NIHSS or GCS) during the
head positioning intervention; C) longitudinal measurement of modified Rankin Score
(mRS) at 6 months; or, D) a combination of both the proximal and longitudinal measures
described.
Prior to distribution, the survey was piloted by providers that mirrored the
targeted interdisciplinary group, including some for whom English was a second
language. During this phase, we encouraged open-ended comments related to the items to
ensure our understanding of any limitations in how the items were developed and
presented. We intently examined responses that could improve survey item content
validity and our findings were used to finalize the survey and ensure its applicability
across international settings.
Survey Assembly and Distribution
The final survey was assembled in SurveyMonkey®, given its acceptance as a
distribution platform worldwide, including more restrictive countries. A variety of survey
distribution methods were used, including invitation by stroke-specific listservs and
social media outlets (Twitter; Facebook) as well as purposive "snowball sampling" with
distribution to a sample of known individuals on each continent requesting these
participants identify and encourage participation of others known to them. The survey
remained open from September 2018 through February 2019 and was reposted on social
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media and listservs twice after the initial posting; purposive contacts were also contacted
twice with the second contact occurring 6 weeks after the initial contact. Participation in
the survey was voluntary and consent was implied by survey completion.
Data Analysis
Data were downloaded, assembled, and cleaned in Microsoft Excel, and imported
to SPSS® 26.0 (IBM) for analysis. Data were carefully reviewed to identify duplicate
entries, of which only 1 participant response was identified and removed prior to
analysis. Nursing and APP participant titles were carefully reviewed and grouped into
appropriate categories, with the final APP category reflecting only those providers with at
least an earned Master’s degree and licensure commensurate with prescribing and
ensuring delivery of evidence-based practice for a particular hospital service or unit.
Participants placed in the “bedside nurse” category consisted only of non-APP nursing
participants. Descriptive statistics were used to summarize the responses and describe the
sample; Mann Whitney U Test was used to determine differences in beliefs and practices
for Likert scale median data, and Chi Squares were used to examine differences in postgraduate years of experience between practitioner professions; statistical significance was
prespecified at ≤0.05. Study findings are presented according to SURGE guidelines
(Grimshaw, 2014).

Results
A total of 181 responses were received representing 13 countries, with the
majority from North America (79%); 11% were from Europe, 7% from Australia/New
Zealand, and 3% from Asia. Participants were 38% advanced practice providers, 32%
were bedside nurses, and 30% were physicians. Participants reported a median of 100
(IQR 37.5-200) hyperacute IPH admissions/year at their facilities.
Overall, participants had 9+8 (median 7) years of post-graduate clinical
experience managing acute stroke patients. Table 4-1 describes participants’ years of
experience and clinical role. Physician respondents (n=54) practiced primarily in North
America (46%), Europe (30%) or Australia/New Zealand (17%) with a small volume
(7%) representing Asia. The majority of physicians were vascular neurologists (57%),
although 15% were neurocritical care physicians and 28% were general neurologists/
hospitalist stroke physicians. Physicians reported 9±8 (median 6) years of acute stroke
management experience. Advanced practice providers (n=69) were from North America
(80%), Europe (16%), and Australia/New Zealand (4%), averaging 8±9 (median 7) years
clinical experience, and bedside nurses (n=58) were from North America (84%),
Australia (12%), and Europe (4%) with an average 9±6.5 (median 7) years of experience;
90% of bedside nurses responding to the survey were neurocritical care nurses, whereas
the remainder were stroke unit nurses. Overall, physicians had fewer years of clinical
experience, with hyperacute IPH after training (9±8, median 6 years), as compared to
bedside nurses and APPs (p=0.009).

36

Table 4-1.

Description of Survey Participants

Characteristic

n (%)

Total Physicians Overall:
Vascular Neurologist
General Neurologist/Hospitalist Stroke Specialist
Neurocritical Care

54 (30%):
31 (57%)
15 (28%)

Post-Graduate Years of
Experience Managing
Acute Strokes
Mean (Median)
9±8 (6) years: *
10±8 (10) years
6±6 (3.5) years

8 (15%)

11±8 (11.5) years

Total Bedside Nurses:
Neurocritical Care Nurse
Stroke Unit Nurse

58 (32%):
52 (90%)
6 (10%)

9±6.5 (7) years:
9±6 (7) years
9±10 (7) years

Total Stroke Team APPs**:

69 (38%)

8±9 (7) years

* Physicians had significantly fewer post-graduate years of experience managing acute
stroke patients compared to APPs and bedside nurses: X2=581; p=0.009.
**APP, Advanced Practice Provider. Physicians had significantly fewer years postgraduate years of experience managing acute stroke patients compared to APPs and
bedside nurses: X2=581; p=0.009.
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A total of 54% of providers indicated that policies and procedures were in place at
their practice sites to maintain head position at 30-degrees in all hyperacute IPH patients.
Table 4-2 provides responses to Likert scale items about practice beliefs and
management of hyperacute IPH patients. Participants “agreed” with the statement
“Written admission orders for hyperacute IPH patients always include positioning the
head at 30-degrees elevation on my unit,” with no difference by provider type. In
responding to the statement “HeadPoST findings provide definitive evidence that head
positioning (elevated to 30-degrees or 0-degrees flat) does not matter in patients with
hyperacute IPH,” physicians and bedside nurses “disagreed” with the statement, while
APPs were “unsure” (p=ns) about agreement. Overall, 53% of participants disagreed and
24% were unsure about the value of HeadPoST findings on head positioning in
hyperacute IPH. In response to the second practice belief statement, “I believe that head
positioning ALONE can influence 6-month outcomes in IPH,” respondents were unsure
(3; IQR:2-3) about agreement with this statement, with no differences in belief found by
profession.
Table 4-3 presents participants’ beliefs about “best” endpoint and endpoint timing
for future hyperacute IPH head positioning clinical trials with breakdown of results by
profession. Overall, 82% of participants recommended use of proximal endpoint
measures: Use of all available technology (ICP and PbtO2) in combination with serial
clinical measures (NIHSS and GCS) was recommended by 68% of participants, and 14%
preferred use of proximal serial clinical measures (NIHSS and GCS) alone. Importantly,
only 14% of respondents believed that a longitudinal measure of functional status using
the modified Rankin Scale (mRS) would be the best measure for a hyperacute IPH head
positioning clinical trial, and 4% believed both proximal and longitudinal endpoints
should be considered. No differences in participants’ beliefs about endpoints and timing
were found by profession.

Discussion
Our survey showed that clinical equipoise is lacking in regard to optimal head
positioning in patients with hyperacute IPH, with participants either not agreeing that
HeadPoST results were definitive or being unsure of the trial’s implications for practice.
Furthermore, head elevation in hyperacute IPH was supported by clinical policies and
procedures in 54% of participants’ hospitals, and there was agreement overall that written
admission orders called for 30o head positioning in hyperacute IPH. These findings may
in part explain why guidelines in the United States, Canada, Australia, and Europe are
either silent or contain recommendations for 30-degree head positioning in hyperacute
IPH patients (Hemphill J. Claude et al., 2015; InformMe―Clinical Guidelines for Stroke
Management, n.d.; Shoamanesh (Co-chair) et al., 2021; Steiner et al., 2014).
We also found that proximal endpoints measured during head positioning
interventions in hyperacute IPH were overwhelmingly supported by our respondents.
This may provide the rationale for why HeadPoST findings are not respected or widely
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Table 4-2.
Participants’ Practices and Beliefs about Head Positioning in
Hyperacute Intraparenchymal Hemorrhage
Respondent Type

Written Admission
Orders for
Hyperacute IPH
Patients Always
Include
Positioning the
Head at 30Degrees Elevation
on
My Unit.
Median (IQR)*

Total Physicians:
Vascular Neurologist
General Neurologist and Hospitalist-Stroke
Specialist
Neurocritical Care

2 (2-3):
2 (2-4)
2 (2-3)

HeadPoST
Findings Provide
Definitive
Evidence That
Head Positioning
(Elevated to 30Degrees or 0Degrees Flat)
Does Not Matter
in Patients with
Hyperacute IPH.
Median (IQR)*
3.5 (2-4):
4 (3-4)
4 (3-4)

1.5 (1-2)

3 (2.25-4)

3 (3-4)

Total Bedside Nurses:
Neurocritical Care Nurse
Stroke Unit Nurse

2 (1-2):
2 (1-2)
2 (1.5-2)

4 (3-4):
4 (3-4)
4 (3-4)

3 (2-3):
3 (2-3)
3 (2-3)

2 (1-2)

3 (3-4)

3 (2-3.5)

Total Stroke Team Advanced Practice
Providers:

I Believe That
Head
Positioning
ALONE Can
Influence 6Month
Outcomes in
IPH.
Median (IQR)*

3 (2-3.5):
3 (2-4)
3 (3-4)

* Likert Scale: 1=Strongly agree; 2=agree; 3=unsure; 4=disagree; 5=strongly disagree.
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Table 4-3.
Participants’ Beliefs about Best Endpoints for Future
Intraparenchymal Hemorrhage Head Positioning Clinical Trials
Respondent Type

Total Physicians:
Vascular Neurologist
General Neurologist and
Hospitalist-Stroke Specialist
Neurocritical Care
Total Bedside Nurses:
Neurocritical Care Nurse
Stroke Unit Nurse
Total Stroke Team Advanced
Practice Providers:

Proximal
Endpoint:
During the
Head Position
Intervention
Using
Available
Technology
(ICP, PbtO2)
& Serial
NIHSS or
GCS

Proximal
Endpoint:
Clinical
Stability
During the
Head
Position
Intervention
Measured by
NIHSS or
GCS

Longitudinal
Endpoint:
mRS at 6
months

Both Proximal
(NIHSS or
GCS clinical
stability &
ICP, PbtO2)
and
Longitudinal
Endpoints
(mRS at 6
months)

% Agreement
59%:
55%
67%

%
Agreement
20%:
19%
20%

% Agreement
15%:
16%
13%

% Agreement
6%:
10%
0

62.5%

25%

12.5%

0

65.5%:
63%
83%

12%:
14%
0

15.5%:
15%
17%

7%:
8%
0

76%

10.5%

12%

1.5%

ICP = Intracranial pressure; PbtO2 = brain tissue oxygenation; NIHSS = National
Institutes of Health Stroke Scale; GCS = Glasgow Coma Scale. No differences noted by
profession; only one category could be selected as the “best” endpoint
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utilized in hyperacute IPH patients due to unanswered questions about how these patients
actually fared during the positioning intervention. Intraparenchymal hemorrhage is a
dynamic process in which critical changes are known to evolve beyond the time of initial
assessment (Maas et al., 2013), with the goal of any intervention being absence of harm.
A proximal endpoint such as neurologic worsening would provide crucial information on
the effect of an intervention in place. This would be best accomplished by use of serial
neurologic assessments utilizing a validated scale such as the National Institutes of
Health Stroke Scale (NIHSS) (Dusenbury, et al., 2019) to detect clinically relevant
changes in determination of stability or deterioration.
The body of work examining the relationship between head positioning and
intracranial hemodynamics demonstrates that among patients with increased ICP,
positioning the head from 0° to 30° significantly reduces ICP (Agbeko et al., 2012;
Davenport et al., 1990; Durward et al., 1983; Feldman et al., 1992; Kenning et al., 1981;
Ledwith et al., 2010; Mahfoud et al., 2010; Meixensberger et al., 1997; Ng et al., 2004;
Ropper et al., 1982; Rosner & Coley, 1986; Schneider et al., 1993; Winkelman, 2000),
although most of these studies included traumatic brain injury patients with few IPH
cases enrolled. Findings from a large cohort of consecutive IPH cases found that only
24% of patients underwent ICP monitoring; however, 70% of these experienced at least 1
episode of ICP reaching values >20 mmHg (Kamel & Hemphill, 2012), raising concern
that increased ICP may occur in many patients without objective confirmation of its
presence. Pressure gradients may also vary in different areas of the brain depending on
hematoma size as well as location, regardless of actual ICP measures (Chambers et al.,
2001), and IPH patients with intraventricular hemorrhage that develop hydrocephalus are
known to experience poor functional outcomes (Diringer et al., 1998; Huttner et al.,
2006; Huttner et al., 2007). Collectively, these findings suggest that head elevation may
in fact be one of the most important first steps in managing hyperacute IPH patients,
particularly in those with hematoma volume ≥30 ml, active bleeding (spot sign positive),
and intraventricular extension (Diringer et al., 1998; Huttner et al., 2006; Huttner et al.,
2007)
Interestingly, we found no differences by profession in opinions about head
positioning practices, beliefs about HeadPoST, or definitive endpoints for a future trial.
This may reflect widespread dissemination across professions of the implications of
increased ICP on clinical outcomes, including head elevation practices that have been
long embedded as standard of care. Additionally, since the characteristics of the
HeadPoST IPH cohort have not been well described, little is known about these patients’
hematoma volume and location, presence of intraventricular extension, availability of
ICP monitoring/measured ICP values, or ICH scores on enrollment, as well as the
etiology of these hemorrhages. These gaps may have contributed to the lack of clinical
equipoise found by our study.
Limitations
Our study has several limitations that must be acknowledged. First, our survey has
not undergone psychometric evaluation and was developed using content expertise.
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However, it was constructed based on the literature and expert providers’ feedback, with
pilot testing and refinement prior to distribution. Second, our distribution methods may
have introduced selection bias. We relied on social media, listservs, and purposive
sampling with snowballing; this may have limited survey circulation. Additionally, we
may also have significantly limited our responses because the survey was distributed
written in English only. However, despite these limitations, our survey return was
considerably larger than that of the pre-trial HeadPoST survey, providing the largest
international survey return to date on head positioning in hyperacute stroke. Lastly, as is
consistent with our survey methods, we assume that respondents answered truthfully and
accurately yet we cannot confirm this.

Conclusions
Despite HeadPoST findings suggesting that head position doesn’t matter in acute
stroke patients, interdisciplinary providers remain unconvinced and continue to favor 30o
head elevation in hyperacute IPH patients. Future work in head positioning of hyperacute
IPH patients should be supported by proximal serial assessment of both clinical and
technology-based measures during the head position intervention to determine if 30degree is indeed optimal and if 0-degree head positioning is safe.
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CHAPTER 5. FEASIBILITY OF CONDUCTING HOB POSITIONING
RESEARCH IN HYPERACUTE INTRAPARENCHYMAL HEMORRHAGE
PATIENTS

Introduction
Intraparenchymal hemorrhage (IPH) is a catastrophic event carrying a fatality rate
of approximately 40% at one month and 54% at one year (An et al., 2017). Perhaps more
unfortunate is the disabling nature of the injury. Only 12-39% of surviving IPH patients
ever achieve long-term functional independence (An et al., 2017).
Several interventions for IPH treatment have been tested over the past 10 years
(Hanley et al., 2017; Hanley et al., 2019; Mendelow et al., 2013; Qureshi et al., 2014;
Qureshi et al., 2016); however, no intervention to date has been shown to reduce the
disability caused by this devastating form of stroke. Head of bed positioning (HOB) may
be an important first step in the management of patients with IPH but no well-designed
studies conducted in exclusively hyperacute IPH patients have yet been conducted. Early
HOB research included heterogeneous neurologic patients, some of which were IPH, but
most subjects had suffered traumatic brain injury and were at risk for increased
intracranial pressure (Chambers et al., 2001; Diringer et al., 1998; Huttner et al., 2006;
Huttner et al., 2007). In recent years, the HeadPoST trial evaluated HOB position and 90day outcome, concluding that HOB position did not make a difference in the management
of either ischemic or hemorrhagic stroke (Anderson et al., 2017). This finding sparked
great debate, with the study design and conclusions heavily criticized by international
practitioners (Alexandrov et al., 2018). Additionally, a recent international survey found
that acute interdisciplinary stroke clinicians disregard HeadPoST findings and continue to
place value in HOB positioning at 30-degrees elevation (Chapter 4). This same study also
documented that these clinicians believe serial clinical measures of stability and
technology-derived measures (i.e., ICP monitoring) obtained at the time of a HOB
intervention would be the most valuable in future studies.
There is a need to understand whether HOB elevation is or is not an important
nursing intervention in vulnerable IPH patients and to characterize the types of IPH
patients that would or would not be affected by changes in HOB height. However, given
the very few numbers of IPH patients admitted to stroke centers each year, the
heterogeneity of this form of stroke, and the highly variable use of technology in these
patients, the feasibility of such a study remains in question. Therefore, we conducted an
exploratory feasibility study to understand instrumentation practices, patient
characteristics and admission volume, assessment methods, and imaging findings as a
first step towards designing future IPH HOB positioning studies.
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Methods
Institutional review board approval was obtained for the conduct of an
observational cross-sectional hyperacute IPH patients admitted to a tertiary care
comprehensive stroke center (CSC) in the Mid-South region of the United States stroke
belt. Patients were included in the study if they were >18 years of age and were admitted
between December 2020 to April 2021 with spontaneous IPH of hypertensive origin.
Exclusions to the study included IPH due to trauma, brain tumors, venous sinus
thrombosis, and IPH resulting from underlying structural vascular lesions.
The medical records of consecutive patients meeting inclusions without
exclusions were reviewed for collection of de-identified data that included demographics,
the HOB position assigned, clinical assessment findings using the National Institutes of
Health Stroke Scale (NIHSS) as well as the Glasgow Coma Scale (GCS), technologyderived measures such as intracranial pressure (ICP) and use of external ventricular
drainage (EVD), neuroimaging findings such as bleed location, hematoma expansion, and
the presence of intraventricular hemorrhage and a spot sign. Hematoma volume was
calculated using the AxBxC/2 method (Kothari et al., 1996) and change in hematoma
volume on serial examinations was used to calculate volumetric change in cubic
centimeters. Hospital measures included total length of stay, neurocritical-intensive care
unit (NICU) days, ventilator days, and discharge NIHSS and modified Rankin Score
(mRS). The availability of post-discharge mRS data at 3 or 6 months was also explored
and if available, captured. Patients were not contacted if these data were unavailable in
hospital records.
Data were entered, cleaned, and analyzed with SPSS (IBM version 25).
Descriptive statistics were used to summarize the findings and describe the sample.
Measures of central tendency for numeric data are presented as median with interquartile
range (IQR) 25th–75th percentile due to the small sample size. Comparisons were made
between groups using Chi Square nonparametric tests.

Results
A total of 39 hypertensive IPH patients were enrolled during the observational
period (Table 5-1). Patients were a median 58 (IQR 52-68) years of age and 54% were
male; all were of non-Hispanic ethnicity, and the majority (77%) were African American
race. The ability to give written informed consent for a future interventional study,
determined by reviewing documentation, was present in only 28% of patients; among
those that would be unable to consent, the availability of family to provide written
informed consent was 96%.
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Table 5-1.

Subject Demographics
Characteristics
Sex
Male
Age
Race
African American
White
Mixed
Primary Language English
Payor Source
Medicare
Private Insurance
Medicaid-state funded
Self-Pay
Veterans Administration
Consent
Patient had ability to consent
Family available for consent

IQR = interquartile range.
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Results
54%
Median 58 (IQR 52-68) years
77%
20%
3%
100%
46%
33%
10 %
8%
3%
28%
96%

Past Medical History
Common comorbidities are listed in Table 5-2; not surprisingly, hypertension was
a known preexisting condition in 90% of patients. Only 20.5% had diabetes, 13% had
hyperlipidemia, 18% had chronic kidney disease, and 13% smoked cigarettes. Overall, a
total of 12 (31%) patients had a history of previous neurovascular events with transient
ischemic attack (TIA) reported in 15%, hemorrhagic stroke in 10%, and 5% of the sample
having a history of previous ischemic stroke.
A total of 25 (64%) patients had been prescribed antihypertensive agents prior to
their IPH hospital admission; prescription drugs were unknown in 9 (23%) patients, and 5
(13%) patients did not use any prescribed agents. Calcium channel blockers (56%), beta
blockers (48%), and diuretics (48%) were the agents most commonly prescribed.
Interestingly, subjects were prescribed a median 2 (IQR 2-3) antihypertensive agents.
Overall, agents were prescribed for the majority of patients in a manner consistent with
Joint National Council 8 recommendations (James et al., 2014), with African Americans
most commonly managed with calcium channel blockers (63%) and diuretics (47%), and
Whites most commonly prescribed angiotensin converting enzyme inhibitors (50%) and
diuretics (50%). However, it was unclear whether patients were compliant with
prescribed medications prior to the IPH event.

Prehospital Management
Emergency Medical Services (EMS) transported patients directly to the CSC 49%
of the time with a median last known well (LKW) time to CSC arrival of 242 (IQR 69697) minutes. Of the remaining patients transferred to the CSC from an acute care
hospital, median time from LKW to CSC arrival was 280 (IQR 160-787) minutes and
was not statistically different from patients that arrived directly to the CSC (X2 = 24; p =
0.52). The EMS “run sheet” documentation describing the care of the patient during
transport, including how the patient’s HOB was positioned, was available for only 10.5%
of patients transferred directly to the CSC (Table 5-3); of those with available EMS
documentation, the HOB was maintained at 30-degrees elevation or higher.
Table 5-3 also presents findings associated with CSC emergency department
(ED) management. Overall, 51% of patients were intubated prior to or during their
hospital stay. Median values for CSC arrival vital signs were systolic blood pressure
(SBP) 195 (IQR 180-222) mmHg, diastolic blood pressure (DBP) 101 (IQR 85-115) mm
Hg, mean arterial pressure (MAP) 133 (IQR 116-153) mmHg, heart rate 88 (IQR 76-99)
beats per minute, respiratory rate 18 (IQR 16-19) breaths per minute, oxygen saturation
99 (IQR 97-100) percent, and temperature 36.6 (IQR 36.6-36.85) degrees Celsius.
Patients that were transferred from another hospital had insignificantly lower SBP
(median 158 [IQR 133-181.25] mmHg; X2 = 34; p = 0.27), DBP (median 82.5 [IQR 68.599.25] mmHg; X2 = 30; p = 0.5), and MAP (median 104.5 [IQR 91.25-127.5] mmHg; X2
= 31; p = 0.42) compared to those arriving directly to the CSC. Laboratory values for the
sample are also presented in Table 5-3.
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Table 5-2.

Past Medical History
Characteristic
Results
Comorbidities
Hypertension
90%
Diabetes
20.5%
Hyperlipidemia
13%
Chronic Kidney Disease
18%
Smoking
13%
Gout
8%
Heart Failure
8%
Atrial Fibrillation
5%
Hypothyroidism
3%
Previous Stroke
TIA
15%
Hemorrhagic
10%
Ischemic
5%

TIA = transient ischemic attack
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Table 5-3.

Prehospital and Emergency Department Characteristics

Characteristics
Arrival to Comprehensive Stroke
Center (CSC)
Patients Transferred Directly to CSC
by EMS
• EMS Runsheet Documentation
Available
Patients Transferred from Outside
Hospital

Results

49%
10.5%
51%

Stroke Onset to Arrival:
Direct to CSC
Transfer to CSC from outside hospital
Airway
Intubated Prior to or in Emergency
Dept.
Ventilator Days
Overall CSC Arrival Vital Signs (All
Patients)
Systolic Blood Pressure
Diastolic Blood Pressure
Mean Arterial Pressure
Heart Rate
Respiratory Rate
Oxygen Saturation
Temperature (n=35)
Admission Labs
Glucose (n=38)
Hemoglobin A1C (n=24)
LDL (n=18)
INR (n=36)
Creatinine (n=36)

Median 242 (IQR 69-697) minutes
Median 280 (IQR 160-787) minutes
20 (51%)
Median 9.5 (IQR 2-15.75) days

Median 180 (IQR 141-200) mmHg
Median 95 (IQR 75-110) mmHg
Median 123 (IQR 97-141) mmHg
Median 84 (IQR 73-98) beats/minute
Median 18 (IQR 16-20) breaths/minute
Median 99 (IQR 97-100) %
Median 36.7 (IQR 36.6-37) Celsius
Median 130.5 (IQR 106-191.75) mg/dL
Median 5.75 (IQR 5.25 – 6.63) %
Median 100.5 (IQR 79.25-114.25) mg/dL
Median 1.0 (IQR 1.0-1.1)
Median 1.1 (IQR 0.8-1.6) mg/dL

Bullet: Additional information for those patients transferred directly to CSC.
EMS, emergency medical service; IQR, interquartile range; LDL, low-density
lipoprotein; INR, international normalized ratio
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Neuroimaging
Table 5-4 presents the samples’ characteristics based on neuroimaging findings.
Most commonly, admitting IPHs were located in the basal ganglia (45%) and thalamus
(31%). On the admitting computed tomography (CT) scan, median hematoma volume
was 10 (IQR 3-19.5) cc; hydrocephalus was evident on 31% of scans, with 56% showing
evidence of secondary intraventricular hemorrhage (IVH) extension. Herniation was
evident on 3 patients’ (8%) CT scans. A CSC admission CT angiography (CTA) scan
was completed in 77% of patients; of these, 2 patients (7%) were spot sign positive,
indicating active bleeding within the hematoma.
Stability CT scans were obtained in 33 patients at a median of 414 (IQR 284514.5) minutes (6.9 hours) from the CSC admitting CT; excluding the 6 patients without
a first stability scan, change in hematoma volume was 0 (IQR 0-1.6) cc. In the 2 patients
that were spot sign positive on the initial CT, mean hematoma growth was 11 (range 418) cc. A second stability scan was obtained in 15 patients at a median 816 (IQR 6411345) minutes (13.6 hours) from the CSC admitting scan; hematoma growth on this
second stability scan was a median 1 (IQR 0-2.35) cc. For the 2 patients with a positive
spot sign, mean hematoma growth was 19 (range 10-28) cc on the second stability scan.
Our small spot sign positive sample precluded measurement of statistically significant
differences in hematoma growth. No further stability scans were performed.

Surgical and Neurocritical Care Management
Table 5-5 presents surgical and neurocritical care management data. The HOB
height used to manage patients within the hospital setting was 30-degrees elevation in all
patients. A total of 5 (13%) patients underwent surgical hematoma evacuation and EVDs
were placed in 12 (31%) patients overall and maintained over a median of 14 (IQR 1414) days. Of patients with an EVD, intraventricular ICP readings were documented in 3
(25%) patients; opening ICP pressures were inconsistently documented in the medical
record so were not collected as part of this study. Of patients with an EVD, intrathecal
tissue plasminogen activator (tPA) was administered to 3 (25%) patients. One patient
(8%) with an EVD had CSF cultures obtained, with no growth evident.

Disability and Functional Status Measures Throughout Hospitalization
Table 5-6 presents disability and functional status measures for the sample.
Premorbid mRS score was a median of 0 (IQR 0-1). Admission NIHSS median was 12
(IQR 5-23), intracerebral hemorrhage (ICH) score was a median 2 (IQR 1-3) points, GCS
score median was 10 (IQR 6-14), and FUNC Score median was 8 (IQR 6-10). Use of the
NIHSS was only evident in 19 patients at 6-hours from CSC admission with a median
score of 11 (IQR 2-22) points indicating an insignificant trend toward worsening of
disability compared to these same patients’ admission NIHSS scores (median 10 [IQR
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Table 5-4.

Neuroimaging Findings in IPH Patients

Characteristics
Location of IPH
Basal Ganglia
Thalamus
Brainstem
Cerebellum
Primary IVH
Secondary IVH Extension
Volume of IPH
Admission
Change in Hematoma Volume on First Stability
Scan (based on 33 patients)
Change in Hematoma Volume on Second Stability
Scan (based on 15 patients)
Herniation on Admission CT
Hydrocephalus on Admission CT
Spot Sign Positive

Results
45%
32%
13%
10%
0
56%
Median 10 (IQR 3-19.5) cc
Median 0 (IQR 0-1.6) cc
Median 1 (IQR 0-2.35) cc
8%
31%
7%

IPH, intraparenchymal brain hemorrhage; IVH, intraventricular hemorrhage; IQR,
interquartile range; CT, computed tomography

Table 5-5.

Surgical and Neurocritical Care Management

Characteristics
External Ventricular Drain:
Placement
EVD Days
Intrathecal Tissue Plasminogen Activator
ICP Monitoring Documented
Cranial Surgery

Results
31%
Median 14 (IQR 14-14) days
25%
25%
13%

EVD, external ventricular drain; IQR, interquartile range; ICP, intraparenchymal
hemorrhagic [stroke]

50

Table 5-6.

Stroke Scale Scores Over Time in Hospital

Characteristics
National Institutes of Health Stroke Scale (NIHSS)
Score
Admission (n = 39)
6 hours (based on 19 subjects)
24 hours (based on 15 subjects)
Discharge (based on 24 subjects)
Intracerebral Hemorrhage (ICH) Score
Admission (n = 39)
Glasgow Coma Scale Score
Admission (n = 39)
6 hours (based on 28 subjects)
24 hours (based on 32 subjects)
Discharge (based on 32 subjects)
FUNC Score
Modified Rankin Scale (mRS) Score
Premorbid (n = 39)
Discharge (n = 39)
Discharge mRS ≥ 3

Results

Median 12 (IQR 5-23)
Median 11 (IQR 2-22)
Median 7 (IQR 4-19)
Median 3.5 (IQR 2-10.5)
2 (1-3)
Median 10 (IQR 6-14)
Median 7 (IQR 6-14)
Median 11.25 (IQR 7.25-14)
Median 14 (IQR 11-15)
Median 8 (IQR 6-10)
Median 0 (IQR 0-1)
Median 4 (IQR 3-5)
79.5%

IQR, interquartile range; FUNC, functional outcome in patients with primary
intercerebral hemorrhage; mRS, modified Rankin Score.
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4-22]; X2 183.4; p = 0.066). The 24-hour NIHSS was recorded in 15 patients with a
median value of 7 (IQR 4-19) points and was not statistically different from these same
patients’ admission NIHSS scores (median 10 [IQR 10-22]; X2 135; p=0.165) yet was
clinically improved. The 6-hour GCS was recorded in 28 patients at a median 7 (IQR 614) points and was statistically worse compared to these same patients’ admission GCS
scores (median 8.5 [IQR 4.5-14]; X2 113; p=0.05). The 24-hour GCS was recorded on 32
patients with a median value 11.5 (IQR 7.25-14) and was significantly improved
compared to the admission GCS in these same patients (median 10.5 [IQR 7-14]; X2 136;
p=0.008).
Overall, patients were usually discharged to home (33%) with or without the need
for home health services, with 25.5% discharged to inpatient rehabilitation facilities.
Eight (20.5%) patients died prior to hospital discharge, with death occurring within 48
hours of hospital admission in 50% of these cases (Table 5-7). Discharge NIHSS was
recorded on 24 (61.5%) patients with median score of 3.5 (IQR 2-10.5) and discharge
GCS was recorded on 32 (82%) patients with median score 14 (IQR 11-15) (Table 5-6).
The discharge mRS was a median of 4 (IQR 3-5) points indicating an inability to walk
independently, with 31 (79.5%) patients having a discharge mRS ≥ 3 indicating poor
functional outcome (Table 5-6). Total Neurocritical Care Unit length of stay was a
median of 3.5 (IQR 1-14.5) days and median overall hospital length of hospital stay was
5 (IQR 3-24) days (Table 5-7). No data were available describing post-discharge mRS or
NIHSS at 3 or 6 months.

Discussion
Our findings indicate that at one busy CSC site in the stroke belt region of the
United States we can expect approximately 8 patients with hypertensive IPH to be
admitted each month, and that of these patients, current HOB height is 30-degree
elevation. This finding suggests that while pilot work could continue within this site, a
multi-site clinical trial is required for a definitive HOB positioning study in hyperacute
IPH patients. We also documented high availability rates of family to provide written
informed consent for participation in future studies should the patient lack the ability to
consent themselves. We were also able to capture data on vital signs and monitoring
practices as well as the use of neuroimaging. This will benefit our siting of a future head
positioning intervention within the current IPH practice model used at this high-volume
hospital, enabling the conduct of a pragmatic protocol that does not disrupt routine
patient care processes.
Problematic findings included the relatively low volume of patients with EVDs,
including the fact that ICP monitoring was not being performed in 100% of EVD
patients; additionally, PbtO2 monitoring was not utilized at all at the study site. This
finding will limit the availability of technology-derived measures in future work
implemented at this study site, although we acknowledge that use of invasive technology
is not always indicated for patients with IPH. Another surprising finding was the lack of
CTA imaging in 100% of cases, thereby limiting our ability to understand the prevalence
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Table 5-7.

Length of Stay and Discharge Disposition

Characteristics
Length of Stay
Total hospitalization
Neurocritical Care Unit
Discharge Disposition
Home (with or without rehab services)
In-patient Rehab
Skilled Nursing/Long Term Care
Long-Term Acute Care
Death
Transfer Out of State
IQR, interquartile range
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Results
Median 5 (IQR 3-24) days
Median 3.5 (IQR 1-14.5) days
33%
25.5%
10%
8%
20.5%
3%

of spot signs and their influence on hematoma expansion. Whether this was due to many
patients requiring transfer to the CSC from an outside hospital resulting in an assumption
that hematoma expansion may have already occurred by the time of arrival, or whether it
was driven by differences in individual provider practices, we are unable to say.
Overall, time from ictus was not significantly shorter in patients that were directly
admitted to the CSC compared to those that were transferred in from outside hospitals,
however our small sample size likely influenced this finding. Others have shown that
time from diagnosis to transfer to definitive care at CSCs can be slowed by internal
hospital processes at the transferring hospital, difficulty arranging transfer from ground
and air transport companies, and even internal CSC factors such as neurocritical care bed
availability (Patterson et al., 2021). This indicates that as part of future pilot work, we
should consider examining time from ictus in relation to response to HOB positions so
that we are able to best determine the types of patients that should be enrolled in a
definitive study, and whether we should include those that are transferred into the CSC.
We also will need to understand how hematoma volume, hematoma location, the
presence of IVH and hydrocephalus interact with HOB position our work has
demonstrated that patients with varying IPH characteristics are available in this study site
so that this can be understood in our future prospective work.
Post-discharge functional and disability measures were unavailable at this study
site as part of standard of care assessment, and because our methods were strictly
observational cross-sectional work and did not include obtaining informed consent to
contact the patient after hospital discharge, we cannot comment on whether these patients
would be able to be reached once they depart the hospital. While measurement of mRS at
90-days is a requirement in ischemic stroke patients who undergo reperfusion treatment,
it is not a requirement for IPH (Ormseth et al., 2017). Therefore, future pilot work should
include written informed consent to contact subjects by telephone at 90- and 180-days
post-discharge to obtain the mRS; should an NIHSS also be planned for these time
points, two stroke clinic visits will have to be scheduled at no charge to the patient and
with payment for parking or transportation.

Limitations
Our work has limitations, chief among these is use of a single site for this study,
collection of data from medical records, and the small conventional sample size that was
included. In particular, the collection of retrospective data was problematic because we
cannot verify the accuracy of these collected data nor the fact that some data were
available but not recorded by the medical team in the record. Our future methods will be
exclusively prospective, with 100% of data collected solely by our study team members
to ensure data validity and accuracy. The use of a convenience sample is problematic in
that it is likely to inject selection bias that is difficult to control for, preventing our
findings from being generalizable to the population-at-large. However, our work does
allow us to understand what medical and nursing care processes occur at the institution
that was sampled, including the technology use, monitoring practices, blood pressure
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management, and the HOB position used in their IPH patients. Despite these limitations,
our primary objective for this study was to determine the feasibility of performing future
HOB positioning studies, and that objective was well served by this process, allowing us
to identify limitations in subject availability, arrival times from ictus, and internal
neurocritical care management processes. This knowledge favorably positions us to
design our next phase of pilot work in a realistic and pragmatic way so that we may
methodically determine the best methods to support a definitive IPH HOB positioning
clinical trial.

Conclusions
The conduct of pilot IPH HOB positioning work is feasible within our local
tertiary care CSC. However, a multi-site approach will be necessary to support the
conduct of a definitive clinical trial examining the efficacy of 30-degree HOB positioning
in patients with hyperacute IPH.
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CHAPTER 6.

CONCLUSIONS

Overall Summary of Findings
Intraparenchymal hemorrhage (IPH) results in devastating disability and high
rates of death. The focus of this program of research has been on examining the
opportunity to institute a nurse-driven head of bed (HOB) intervention to understand the
contribution of head positioning to IPH patient stability or worsening. This dissertation
has methodically explored important factors that will play a part in the design of future
HOB research as well as the acceptability of findings among international clinicians. This
closing chapter summarizes and synthesizes the findings from our research presented in
this work, with a focus on implications for the design of future IPH HOB research in
hyperacute patients.

Nursing Neurologic Assessment
Chapter 2 examined the necessary nursing knowledge and skills needed to
understand how to assess clinical change in relation to vascular territories in the brain.
While IPH often extends beyond the boundaries of discreet vascular territories, the
information obtained through serial assessments remains important in understanding the
extent of clinical worsening that can occur with hematoma expansion.
The education and training that nurses receive can improve health outcomes in
people who have experienced a stroke (Jones et al., 2018); however, nursing education
inadequately prepares nurses to assess patients in a manner that promotes localization of
neurologic findings (Lee & Sim, 2019), thereby creating a need for relevant acute stroke
continuing education and clinical training. In fact, the viewpoints of academic and
practice leaders often diverge when it comes to determining what educational content is
relevant to practicing nurses; closure of this gap will take a dedicated and coordinated
response from academics and clinical nursing leaders (Huston et al., 2018). Saifan and
colleagues (2021) suggest that future nursing education methods should be directed to
development of clinical skills that include both communication and practice application
using real patients that differs significantly from simulated patients as these skills can
otherwise be difficult to acquire. Chapter 2 supports this proposition by providing
essential knowledge and relatable clinical assessment skills for nurses. Furthermore, its
content supports our ability to select future sites staffed by acute stroke nurses and
advanced practice providers capable of mastering these localizing skills for participation
in a definitive multi-site study of HOB positioning in hyperacute IPH patients.
In Chapter 3, we presented our work validating use of the National Institutes of
Health Stroke Scale (NIHSS) in IPH. The NIHSS was developed for use in clinical trials
examining reperfusion therapy outcomes in acute ischemic stroke patients treated with
tissue plasminogen activator (tPA) but has since become standard of care for ongoing
assessment in ischemic stroke regardless of reperfusion treatment status (Brott et al.,
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1989; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group,
1995). Use of the NIHSS provides a common language and an ability to quantify
neurologic disability using a standardized approach to the clinical exam. There has been
lack of consensus on the use of a specific scale for baseline and serial assessment in the
IPH patient (Nye et al., 2012). Mortality is better predicted by the NIHSS than Glasgow
Coma Scale (GCS) (Hosomi et al., 2009), and our work found that the NIHSS also
discriminates better than the GCS for large admission hematoma volume and poor
functional status at 24 hours. Use of the NIHSS may improve early recognition of
neurological deterioration before changes occur in level of consciousness. The NIHSS
may also allow recognition of mounting disability developing over time with hematoma
expansion or hydrocephalus, enabling better prognostication and earlier implementation
of injury-reducing strategies.
Ongoing neurologic assessment is foundational to the work of acute stroke nurses
and essential to the rapid detection of actionable clinical changes in hyperacute IPH
patients (Finocchi et al., 2018). Collectively, our work covered in Chapters 2 and 3
elevates the knowledge, clinical skills, and roles of bedside and advanced practice acute
stroke nurses, while providing them with a valid instrument for ongoing serial
assessments of acute IPH patients.

Beliefs and Practices of Healthcare Providers
Chapter 4 presented our manuscript exploring beliefs and practices of
interdisciplinary providers that care for hyperacute IPH patients. The Head Positioning in
Stroke Trial (HeadPoST) concluded that head positioning has no effect on patient
outcomes measured at 3-months after onset (Anderson et al., 2017). Although HeadPoST
results have been highly criticized, it was unknown whether clinical equipoise existed
surrounding the use of head positioning in hyperacute IPH after the study’s publication
(Alexandrov et al., 2018) knowledge of what interdisciplinary practitioners believed to be
the most valid endpoints for a future head positioning trial was also lacking. Our findings
clearly demonstrate that regardless of HeadPoST findings, our international sample
continues to favor use of 30-degree HOB elevation in the management of hyperacute IPH
patients, with clinical policies and procedures as well as written admission orders
supporting use of head elevation in most participants’ hospitals.
The use of HOB elevation is theoretically sound in the hyperacute phase of IPH
management and may be the most important first action that can be easily implemented to
support these highly vulnerable patients. Our results support the need for further research
to definitively determine the contribution of HOB position to patient stability or deterioration, and our findings demonstrate overwhelming support for serial measurement of
clinical and technology-derived endpoints captured during delivery of the intervention, a
design flaw that was overlooked by the HeadPoST investigators (Alexandrov et al.,
2018).
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Intraparenchymal hemorrhage is a dynamic process in which critical changes are
known to evolve beyond the time of initial assessment (Maas et al., 2013), and the goal of
any intervention is benefit in the absence of harm. Collectively, development of
localization knowledge and clinical skills, use of the validated NIHSS instrument in
hyperacute IPH patients, and knowledge that performance of serial NIHSS and technology-derived measures during delivery of a head positioning intervention are valued by
acute stroke clinicians will help guide our future research, while allowing us to ensure
patient safety. Our future pilot work should include a repeated measures study of head
position at 0- and 30-degrees using these methods to provide an estimate of effect size in
relation to both hematoma location and volume.

Exploration of Feasibility Factors in the Conduct of IPH HOB Research
Chapter 5 examined the feasibility of conducting a future IPH HOB positioning
trial in a Mid-South tertiary comprehensive stroke center (CSC), examining the
availability of subjects, subject characteristics, availability of technology-derived
measures, and other key implementation factors such as ability to consent and current
HOB positioning practices. Our survey findings (Chapter 4) directed our selection of the
practices and endpoint measures that were inventoried in this feasibility study. While
many of these practices and measures were present in the review of medical records,
many key measures were missing, including the surprising finding of missing intracranial
pressure (ICP) measures in patients with external ventricular drains (EVD), postdischarge disability, and functional status measures. Collectively, this makes clear the
need for a researcher to collect these measures prospectively as we move forward, instead
of relying on recorded medical record or stroke registry data.
Most importantly, we were able to identify the number of IPH patients admitted to
one high-volume tertiary care CSC site in the stroke belt region of the United States,
finding that there were sufficient numbers of patients to support conduct of prospective
pilot work but insufficient numbers to use this facility as the sole site for a definitive
study of head positioning in hyperacute IPH patients. Additionally, there were very few
patients that had any form of instrumentation such as ICP monitoring, and there was no
use of brain tissue oxygenation monitoring (PbtO2) at this study site. Our work in Chapter
2 which built nursing localization knowledge and clinical skills, as well as that in Chapter
3 which demonstrated the validity of the NIHSS as a clinical disability measure for acute
IPH patients, will support our recruitment of sites with knowledgeable, highly skilled
nurses for a definitive clinical trial of head positioning in the future, but we will also need
to pursue recruitment of sites that use multimodal brain monitoring (ICP and PbtO2) to
enable capture of technology-derived measures during HOB manipulation.

Discussion of Limitations and Strengths
Our work has limitations. Arguably, a significant limitation is that the studies in
Chapters 3 and 5 were conducted at one center in one geographical location managed by
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one group of providers overseeing clinical care. As we move forward, we intend to
enlarge the data to see whether it supports our current findings of the validity of the
NIHSS in acute IPH patients (Chapter 3) to include data from other sites as well as
longitudinal outcomes measured at 3- and if possible 6-months. We also need to assess
sites carefully for participation in future IPH HOB positioning studies to ensure that they
offer sufficient patient volume and use of technology-derived measures.
An additional limitation to our work was use of an unvalidated survey (Chapter
4). However, we deliberately tailored our questions to reflect those used in the original
survey conducted by HeadPoST investigators prior to the conduct of their clinical trial.
Additionally, we utilized international interdisciplinary neurocritical care and vascular
neurology content experts to aid in the construction of our survey. We also piloted the
survey using a diverse group of practitioners (bedside nurses, physicians, and advanced
practice providers), including those for whom English was a second language; this
allowed us to further refine the survey prior to circulating it.
The strengths of this collective work are in its ability to serve as a foundation to
support future clinical trial pilot studies and ultimately a definitive study of HOB
positioning in hyperacute IPH patients. The research presented in Chapters 2-5 provides
important direction for our next steps in understanding the contribution of HOB
positioning to the management of vulnerable IPH patients.

Implications for Future Research
For hyperacute IPH HOB research to be generalizable a multisite clinical trial will
need to culminate from this and future pilot work, enrolling patients from a variety of
geographic locations. Because IPH is a less common type of stroke with a heterogeneous
population, it will be important to select many tertiary CSC sites to improve the
efficiency of subject enrollment. Future work will help to understand more about the
specific characteristics of responders to a HOB intervention, as well as the estimated
sample size necessary to conduct a definitive clinical trial.
We learned in the feasibility study (Chapter 5) that our local site will allow us to
recruit a high volume of African American IPH patients, whereas other races were not
well-represented. Additionally, ethnicity in our sample was limited to non-Hispanics. As
we move forward, we will need to consider sites capable of recruiting a variety of races
and ethnicities. Asians are well-documented to carry the highest rates of IPH worldwide,
so inclusion of sites admitting a high volume of Asian patients should also be considered
(van Asch et al., 2010).
Our feasibility study (Chapter 5) showed that use of invasive ICP monitoring was
limited in our sample and, surprisingly, even in patients with EVDs; additionally, there
was no use of PbtO2 monitoring in the patients managed at our local clinical site. Given
the interest in a variety of technology-derived measures identified in our survey (Chapter
4), we will need to assess the use of these measures at potential enrolling sites as we
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move toward implementing a definitive multi-site clinical trial of HOB positioning in
hyperacute IPH. Measurement of ICP by intraventricular methods is considered the gold
standard (Harary et al., 2018), producing accurate/reliable findings while also allowing
CSF drainage as a treatment for increased ICP (Czosnyka & Pickard, 2004). However
ventricular ICP monitoring may not be suitable for all types of patients; there is also a 57% risk of tract hemorrhage during insertion (Binz et al., 2009; Bauer et al., 2011) and a
risk of infection with long-term use or frequent opening of the system (Czosnyka &
Pickard, 2004). Despite these limitations, it will be important to standardize our approach
to ICP measurement and exclude other less reliable measures such as subarachnoid and
implantable micro-transducers, as well as optic nerve sheath diameter (ONSD) and
imaging based methods (Harary et al., 2018). Given our local expertise in transcranial
Doppler (TCD), we may also want to consider use of TCD mean flow velocity measures
obtained by head-frame mounted transducers in our pilot work to examine changes in
pulsatility reflective of increased resistance to blood flow in different head positions
(Alexandrov et al., 1998). However, because TCD skills are lacking in most facilities, we
will be limited to using these findings to support the theoretical basis of our work but will
be unlikely to perform such measures at other sites in a definitive clinical trial. Overall,
the limited number of patients undergoing EVD insertion/ICP monitoring and the
inability to generalize use of TCD at other sites, increases the importance of our work
validating the NIHSS as a serial clinical measure in acute IPH patients (Chapter 3).

Conclusions
Patients with hypertensive IPH suffer significantly higher rates of disability and
death than other forms of stroke, yet despite a great deal of inquiry into interventions to
improve outcomes, none have been successful. Positioning the patient’s HOB at 30degrees may be one of the most important early interventions for hypertensive IPH
patients. As the most constant bedside presence charged with continuous surveillance of
patient well-being, nurses are well placed to implement a HOB positioning intervention
and monitor the effect of this simple maneuver on patient outcomes.
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